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ABSTRACT
Ion channels are essential mediators in nervous signaling pathways. Because
hyperactivation of ion channels can lead to pathological disorders such as congenital
myasthenic syndromes and neurodegeneration, channel inhibitors are potentially useful in
the treatment of channel-associated diseases. Open-channel blockers are channel
inhibitors that transiently occupy the open pore of ion channels and impede current flow.
They have been used in both clinical treatments of diseases and fundamental researches
of synaptic transmission. However, the rational design of open-channel blockers is
challenging, mainly due to the paucity of high-resolution structures for the pore regions
of ion channels. The work presented in this thesis aims to test an alternative strategy for
designing open-channel blockers. The proposed strategy utilizes the flexibility of a
polymer backbone, poly(ethylene glycol) (PEG), to maximize blocker-pore interactions.
A proof-of-concept study is presented for the muscle-type nicotinic acetylcholine
receptor (AChR). Single-channel electrophysiological measurements with a series of
PEG-trimethylammonium (PEG-TMA) conjugates show that short bivalent PEG-TMAs
containing four to thirteen ethylene oxide units in the backbone block the open AChR in a
length-dependent manner. Both the blocking and unblocking rate constants decrease
with increasing backbone length. Replacing the TMA moiety with other small
quaternary ammonium (QA) groups further enhances the blockade affinity. The ability
of a PEG-based blocker to stimulate AChR opening is also sensitive to the QA structure.
The PEG-based blockers tested in this thesis interrupt AChR currents with a broad range
of kinetics (blocking rate constant: 10-170 pM-'s-; unblocking rate constant: 2-35000
s') and pore affinities (equilibrium dissociation constant: 0.1-850 jiM). The blocking
rate constants of the PEG-based blockers are consistent with those of previously reported
open-channel blockers for the AChR. The fastest and slowest unblocking rate constants
of the tested molecules are similar to that of acetylcholine and (+)-tubocurarine,
respectively. The results from this pilot study provide useful insights into the future
design of kinetically tunable open-channel blockers.
Thesis Supervisor: Stuart S. Licht
Title: Assistant Professor of Chemistry
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Chapter One
Exploring New Strategies for the Design of
Open-Channel Blockers
This chapter provides background information about the work presented in this
thesis: the design, synthesis, and mechanistic studies of poly(ethylene glycol)-based
(PEG-based) open-channel blockers for the nicotinic acetylcholine receptor (AChR).
The following topics are discussed: the physiological effects and therapeutic importance
of open-channel blockers, the challenges of designing open-channel blockers, the
proposed design strategy, the characteristics of ion channel used for testing our
hypotheses, and the techniques performed for characterizing the synthesized blockers.
The results of a pilot study for the design strategy are presented and discussed in Chapters
Two and Three.
1.1. Ion Channels as Therapeutic Targets
Ion channels are pore-forming integral membrane proteins which mediate the
passive transport of ions across the cell membrane. They can be categorized by their
preferred permeant ions (e.g., Na , K+ , Ca2+ or CE) or by their mechanism of activation.
In the latter classification, the two most common types of ion channels are ligand-gated
and voltage-gated channels; these types of channels open in response to ligand (agonist)
binding and changes in the electric field across cell membrane (i.e., membrane potential),
respectively [1]. Other types of channels can respond to temperature changes [2, 3] or
mechanical force [4]. Ion channels are essential mediators of signaling in the nervous
-13-
system [1]. They also play important roles in other physiological processes, including
the mediation of cardiac rhythm [5, 6], T-cell activation [7], and insulin secretion [8, 9].
Malfunction of ion channels may cause serious health problems such as congenital
myasthenic syndromes [10], neurodegeneration [11], cystic fibrosis [12], and diabetes
[13]. Because of their physiological importance, ion channels are a major class of drug
targets [11, 12, 14-20]. Small molecules that enhance or inhibit the activities of
dysfunctional channels have been used clinically. For instance, memantine, a
compound that blocks excessive activity of the N-methyl-D-aspartate (NMDA) receptor,
is used for the treatment of Alzheimer's disease [21]. Diazoxide, an opener of the
ATP-sensitive potassium channels, is used to suppress excessive insulin secretion [22].
1.2. Open-Channel Blockers and Their Therapeutic Applications
Abnormally high channel activities are detrimental to cells. In the cases of
muscle-type nicotinic acetylcholine receptor (AChR) and NMDA receptor, the excessive
channel activities cause overload of calcium ion (a secondary messenger for signaling
initiation) in the postsynaptic cells, leading to cellular damage or death. At the
neuromuscular junction, the muscle-type AChRs open upon recognizing the chemical
signals (i.e., the acetylcholine molecules) released from the presynaptic neuron. In the
patients with "slow-channel" congenital myasthenic syndrome, the decay of postsynaptic
currents is slowed due to the prolonged durations of the AChR openings. The prolonged
AChR openings result in the degeneration of junctional folds, loss of AChR from the
folds, changes in postsynaptic morphology, and apoptosis under the endplate regions
[10]. Overactivation of the NMDA receptor by an excessive amount or the prolonged
-14-
presence of glutamate, a key excitatory neurotransmitter in the nervous system, leads to
damage or death of neuron cells. NMDA receptor-mediated exitotoxic damage is
believed to contribute to the cause of dementia and Alzheimer's disease [21]. Channel
inhibition is therefore an important approach for treating neurological or neuromuscular
disorders that are associated with hyperactive channels.
The activity of an ion channel can be inhibited via several different mechanisms
(Figure 1.1). One direct way of obstructing current influx/efflux through an open
channel is to sterically occlude the open pore, a mechanism called open-channel blockade
(Figure 1.1, mechanism A). In this mechanism, an open-channel blocker enters the
transmembrane lumen of a channel and interacts noncovalently with the pore-lining
residues. Alternatively, channel activity can be inhibited by preventing a closed channel
from opening or promoting the closure of an open channel (Figure 1.1, mechanisms B
and C). Unlike other channel-inhibition mechanisms, open-channel blockade allows a
channel to open and close normally in response to stimuli but transiently and reversibly
impedes current flowing through the open pore. The ability to allow channels to
function normally is a beneficial feature in some clinical applications. For instance,
drugs that compete with glutamate or glycine at the agonist sites of the NMDA receptor
may lead to unwanted side effects such as drowsiness, hallucination, or coma [21, 23].
- 15-
<closed > <blocked>
Figure 1.1. A simple schematic illustration of channel inhibition mechanisms. (A)
Open-channel blockade. (B) Prevention of channel opening. (C) Promotion of channel
closure. In the case of ligand-gated channels, mechanism (C) may take the form of enhancing
either channel closing or desensitization (channel closing and desensitization are defined in
Chapter 1.5 and Figure 1.7).
1.3. The Effects of Open-Channel Blockade on Channel-Mediated Currents
Open-channel blockade can cause different effects on channel-mediated currents
depending on the kinetics of blockade (Figure 1.2) [1, 20]. In the presence of an
open-channel blocker, the current from each channel is repetitively interrupted by blocker
association/dissociation before the channel closes. At the single-channel level, the
open-state currents are interrupted by blockade events, leading to shortened apparent
open durations. The appearances of single-channel currents are distinct at different
blocker dissociation rates. When the blocker dissociates rapidly (blockade duration
-millisecond or less), the brief blockade durations convert each opening into a burst of
"flickering" events (Figure 1.2A). If blocker dissociation is too fast to be well-resolved
by the recording device, blockade events may not be observed but manifest themselves as
the additional noise of the open-state currents. In this scenario, the measured amplitude
of single-channel currents is reduced (Figure 1.2B). When the blocker dissociates
slowly, blockade events may not be well-distinguished from the closed durations between
successive channel openings. The open durations are shortened, but the burst-like,
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flickering features of single-channel currents are not observed (Figure 1.2A). At the
whole-cell level, fast blocker dissociation leads to a slower decay of macroscopic current
[24, 25], whereas slow blocker dissociation accelerates the decay [26, 27] (Figure 1.2A).
The amplitude of macroscopic currents are also reduced by open-channel blockade;
however, when blockade kinetics are very fast, this effect may be very small [20] (Figure
1.2A and B).
A
open
single-channel
currents
closed
whole-cell
currents
<no blockade> <fast unblocking> <slow unblocking>
I I I I I I I I
blockade events
no blockade no blockade
fast unblocking slow unblockingsl lckn
-
-
-
-
----
I
stimulation stimulation
<fast, resolved unblocking>
JIULJHJIJ
no blockade
i
stimulation
<unresolved unblocking>
n o blockade
unresolved
\ 4-r unblocking
stimulation
Figure 1.2. Effects of open-channel blockade on single-channel and whole-cell currents. (A)
Effects of resolvable fast and slow blockade on single-channel (up) and whole-cell (bottom)
currents. (B) Effects of well resolved and poorly resolved blockade on single-channel (up) and
whole-cell (bottom) currents.
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Figure 1.3. Structure of representative open-channel blockers. AChR, acetylcholine receptor;
NMDAR, N-methyl-D-aspartate receptor.
Open-channel blockers with different blockade kinetics are used in various
applications. Tetraethylammonium (TEA), a fast blocker for potassium channels, was
previously used to prolong postsynaptic responses for the study of temporal precision in
action potential firing [28]. In channel-directed therapeutics, the blockade kinetics,
particularly the dissociation rate of an open-channel blocker, is an important factor for
drug effects. For instance, for the treatment of "slow channel" congenital myasthenic
syndromes, a long-lived blocker for the AChR (such as quinidine, Figure 1.3) is needed
to accelerate the decay of postsynaptic currents [29]. However, long-lived blockers for
the NMDR receptors, such as MK-801 (Figure 1.3) and phencyclidine (PCP, Figure 1.3),
cause serious side effects including drowsiness, coma, and hallucination. A
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lower-affinity blocker of the NMDA receptor, memantine (Figure 1.3), was instead used
clinically for the treatment of Alzheimer's disease [21]. The optimal ranges of blockade
kinetics and affinity are therefore case-dependent.
1.4. The Proposed "Structure-Independent" Strategy for Blocker Design
Although open-channel blockers have great values in both fundamental research
and clinical treatment, rational design of open-channel blockers has been challenging,
mainly due to the paucity of high-resolution structures for ion channels. The majority of
ion-channel modulating drugs, including open-channel blockers, were identified from
screening [30], and the structure-activity relationships between drug actions and channel
structure are not well-established yet. In a typical structure-based design for protein
inhibitor, a high-resolution structure of the inhibitor binding site is required for docking.
However, only a handful of channel structures have been solved at high resolution, and
many of them only present part of the whole channel complex [31]. By far the best
studied structures are those of potassium channels overexpressed in prokaryotic cells.
Crystal structures for both open [32] and closed [33] states were solved. For
ligand-gated channels, only the whole-channel structures of the AChR (in the Torpedo
electric organ) [34, 35] and a prokaryotic homologue (in Erwinia chrysanthemi) [36]
have been determined. The prokaryotic and Torpedo ligand-gated channel were solved
by crystallography (at 3.3 A) and electron microscopy (at 4 A), respectively, both in the
closed conformation. Selected domains for several channels are also solved, but the
detailed architectures of open-channel pores are poorly understood [31 ].
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Nonetheless, modulation of blockade kinetics within a series of compounds can
be feasible. Previous work on AChR blockade by a series of piperazinium (PIP, Figure
1.3) derivatives showed that the blocker dissociation rate constant varies systematically
with the length of the alkyl tail [37]. By extending the length of the alkyl tail from one
to six carbons, the blocker dissociation rate decreased from 1.4 x 105 s-1 to 9.8 x 102 s-,
leading to a -80-fold enhancement in the blockade affinity. The contribution of each
methylene unit to the retardation in blocker dissociation was shown to be additive, with
an increase of 2.4 kJ/mol per extension of methylene group in the activation free energy
for dissociation. In a separate study by Subramahiam et al., unbranched n-alkyl
diamines (Figure 1.3) were also found to exhibit length-dependent enhancement in the
blockade affinity for the NMDA receptor [38]. The binding energy of n-alkyl diamine
was found to increase 0.6-0.7 kcal/mol per extension of methylene unit. In both studies,
the effects on blocker dissociation and/or blockade affinity were attributed to the
hydrophobic interactions between the blocker and the channel pore [37, 38]. These
observations indicate that the dissociation rate and/or affinity of an open-channel blocker
can be systematically modulated if the interactions between the binding element and the
transmembrane pore are additive.
Because the transmembrane lumen of an ion channel is lined mostly by non-polar
residues [1, 39], it is generally believed that open-channel blockers bind within channel
pores via hydrophobic interactions [37-39]. However, most of the open-channel
blockers that exhibit appreciable blockade affinities have a rigid and/or complex structure
(Figure 1.3). It is very likely that these molecules dock in the pore region with specific
orientations, and therefore the effects of modifying the molecular structure on blockade
- 20 -
behavior are difficult to predict without a clear understanding about the binding site
geometry. Moreover, a rigid or complex scaffold might have limited versatility in
blocker modifications due to the possible synthetic difficulties.
The work presented in this thesis aims to explore a new design strategy for
open-channel blockers. The goal of this strategy is to allow blockers spanning a broad
range of blockade kinetics/affinities to be developed without the detailed structure of the
open-channel pore. The scaffold used in this strategy is hoped to be simple and
versatile, allowing an easy expansion of structural diversity from the parent blocker. In
contrast to the rigid hydrophobic cores in the known blockers, a highly flexible scaffold is
considered in the proposed strategy (Figure 1.4). A blocker possessing a flexible
backbone is expected to enter the channel pore through partitioning. Once in the pore,
the blocker can adopt a conformation that maximizes favorable interactions with the
pore-lining residues due to its backbone flexibility. According to the study of PIP
derivatives and n-alkyl diamines, binding affinity can be modulated by the extent of
non-polar interactions between the blocker and the pore interior [37, 38]. For the
proposed blocker, the extent of blocker-channel interactions, which determines the
blocker dissociation rate and/or affinity, is designed to be modulated by adjusting the
backbone length or modifying the decorating groups attached to the backbone.
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Figure 1.4. A schematic illustration of the proposed blocker design strategy. The putative
blockers possess a flexible backbone and one or more decorating groups attached to the
backbone. For simplicity, only the flexible backbones of the blockers are shown. Both the
backbone and the decorating groups are expected to interact with the channel pore. When a
polymer backbone is used, the interaction between each monomer unit and the channel is
expected to be additive and approximately identical.
Polymers that have a flexible backbone serve as promising scaffolds for the
proposed strategy. Although not yet adopted as building blocks for open-channel
blockers, some polymeric and oligomeric materials have been shown to enter the pores of
simple prokaryotic channels and interrupt ion conductance through the pores [40, 41].
These materials include poly(ethylene glycol) (PEG) [42-49], polynucleotides [50-52],
cyclodextrin [53], and dendrimers [54], and their abilities to enter bacterial channels have
been utilized in designing stochastic biosensors [40, 41]. Among these polymers, PEG
appears to be a promising scaffold for our proposed blocker design. It has a simple
composition: it is a linear polymer composed of repetitive ethylene oxide units
(-CH2CH20-) and terminated by a hydroxyl group at each end. The backbone is highly
flexible, and therefore it is potentially capable of being confined within the
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transmembrane lumen, allowing each ethylene oxide unit to interact with the hydrophobic
luminal environment. It has been previously demonstrated that sulfhydryl-directed PEG
reagents can enter the transmembrane pore of a bacterial channel and label the luminal
cysteine residues [55]. At the single-channel level, partitioning of PEG into a
transmembrane pore causes a decrease in the amplitude of single-channel currents and/or
an increase in current fluctuation [42-49]. Discrete blockade events have been observed
in high-resolution single-channel recordings, and kinetic analysis of single-channel
events showed that both association and dissociation rates of PEG depend on its
molecular weight [48]. All of these observations suggest that PEG can be a promising
candidate for our blocker scaffold.
Although free PEGs have been demonstrated to block simple bacterial channels,
the channel-blocking features were observed at very high concentrations (at least
millimolar) that are far from the concentration range for practical applications. In order
to create PEG-based blockers with appreciable pore affinities, a search for structural
determinants is needed. Two structural characteristics of the putative blockers can be
varied to improve pore affinities (Figure 1.5). First, additional decorating groups would
be needed to facilitate blocker binding. Such decorating groups can be installed at the
termini of PEG (Figure 1.5). For cation-permeable channels, one reasonable choice of
the decoration group would be a charge-carrying moiety. It is generally believed that
both cationic and hydrophobic moieties are required for open-channel blockers of
cation-selective ion channels such as AChRs, glutamate receptors, and potassium
channels [39]. The charged moiety is thought to provide electrostatic interactions with
the transmembrane electric field, and the core moiety is believed to interact with the pore
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interior. The charge, size, and shape of the decorating groups may play an important
role in the blockade behavior of a PEG-based blocker. Second, a proper range of PEG
length needs to be identified. The confinement of a polymer in a nanoscale tube entails
an entropic cost: the larger the polymer, the higher the energy barrier that prevents the
polymer from entering the pore [55, 56]. A proper PEG length would be short enough
to reduce this entropic cost for entrance but long enough to provide substantial
interactions with the pore interior.
decoration groups
(charge, size, shape)
I I
flexible backbone
(length)
Figure 1.5. Strategies for determining the structural determinants of PEG-based blockers. The
blockade behavior of a PEG-based blocker is hypothesized to be determined by both the length of
the PEG backbone and the properties (such as charge, size, and shape) of the decorating groups
attached at the PEG termini. Note that the two decorating groups are not necessarily identical.
Our proposed strategy aims to develop open-channel blockers that span a broad
range of blockade kinetics and affinities, with the hope that the blockade behavior can be
systematically modulated by the physical properties of the blocker components. In this
thesis work, the proposed blocker design strategy is investigated using the adult
muscle-type AChR, a well-studied non-selective cation channel, as the target system. In
order to characterize the effects of synthesized molecules on AChR currents, patch-clamp
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techniques are performed to acquire single-channel events. The blockade kinetics and
affinities of synthesized molecules are determined via the analysis of open and closed
events in the single-channel recordings.
In brief, by choosing small quaternary ammonium (QA) groups as the decorating
moieties, the resulting PEG conjugates are capable of interrupting single-AChR currents
at a broad range of kinetics (blocking rate constant: 10-170 pM-ls-'; unblocking rate
constant: 2-35000 s-'), leading to open-channel blockade with various affinities
(equilibrium dissociation constant: 0.1-850 tM). The identification of the structural
determinants for PEG-based blockers is presented in Chapter Two, including the
investigation of the number of QA groups required and the effects of PEG length on
blockade behavior. The characterization of the effects of end-group structure on
blockade kinetics is presented in Chapter Three. To allow a better understanding about
the work presented, the target channel (AChR), patch-clamp techniques, and
single-channel analysis are briefly described in sections 1.5-1.7. The results from this
pilot study are reviewed at the end of Chapter Three with a discussion on future
perspectives.
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1.5. The Muscle-Type Nicotinic Acetylcholine Receptor (AChR)
The muscle-type AChR provides a useful test system for evaluating the proposed
design strategy, since a wealth of kinetic and structural information is available for this
channel [57-61]. The nicotinic AChR is a pentameric transmembrane protein present in
high density in the postsynaptic membrane of the neuromuscular junction. The primary
function of this channel is to convert the neurotransmitter signal, released from the
terminal of the presynaptic neuron, into a transmembrane ion inflx in the postsynaptic
muscle fiber. Upon binding two molecules of neurotransmitter (i.e., acetylcholine;
ACh), an AChR undergoes conformational changes to open the "gate" region embedded
in the transmembrane pore, allowing small cations to pass. The brief openings of
AChRs depolarize the postsynaptic membrane, which in turn triggers the downstream
signaling pathways to stimulate muscle contraction [62]. Defects in the function,
expression, and postsynaptic assembly of the AChR may cause neuromuscular disorders
named congenital myasthenic syndromes [10, 63].
The muscle-type AChR serves as the prototype member of the "Cys-loop"
superfamily of neurotransmitter-gated ion channels, including neuronal AChRs,
y-aminobutyric acid type A (GABAA) receptors, 5-hydroxytryptamine type 3 (5-HT 3)
receptors, and glycine receptors [58]. The AChR is a large glycoprotein (-290 kDa)
assembled as a ring of five homologous subunits. There are two forms of the
muscle-type AChRs differentially expressed depending on the developmental stage: the
fetal type contains a, y, a, ,J, and 3 subunits (arranged in the clockwise order when
viewed from the synaptic cleft) and the adult isoform comprises a, e, a, ,f, and 6 subunits
(Figure 1.6C). Each subunit can be divided into three domains: a large N-terminal
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extracellular domain, a membrane-spanning domain, and a smaller intracellular domain
(Figures 1.6A and 1.6B). The extracelluar domains form a long, -20 A-wide central
vestibule and are involved in agonist binding. The membrane spanning domains are
each composed of four a-helical segments (M1-M4). In particular, the M2 helices form
the inner shell of the transmembrane pore where ion permeation takes place. The
ion-permeable pore is followed by another vestibule formed by the intracellular domains.
The large cytoplasmic loops connecting M3 and M4 helices contain phosphorylation sites
and are involved in receptor biosynthesis, assembly, transport, clustering, and modulation
[61].
The structure of the intact closed channel (from Torpedo marmorata) has been
revealed by electron microscopy at 4 A resolution [34, 35]. The electric organ of
Torpedo electric ray is a rich source of the AChR (composed of the fetal-type subunits)
and has been used extensively in physiological and biochemical studies of
neurotransmission. The structure provides a detailed molecular view of the essential
structural components of the AChR. Detailed information about the extracellular
domains has also been elucidated by the crystal structure of acetylcholine-binding protein
(AChBP, from mollusc glia cells) at high resolution [64-67]. AChBP is a soluble
homologue (both structural and functional) of the extracellular domain of the AChR.
Structures of unliganded [64] and ligand-bound [65-67] AChBPs provide important
information about conformational changes induced upon ligand binding. More recently,
the X-ray structure of a prokaryotic pentameric ligand gated ion channel (from Erwinia
chrysanthemi) has also been reported, providing a model system for studying the
homologous eukaryotic channels including the AChR [36].
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Figure 1.6. The structure of the AChR. (A) General topology of an AChR subunit. (B) The
surface map of Torpedo AChR (PDB entry: 2BG9) [35]. Only three subunits (from left to right:
5
, a, y) are plotted in order to show the inner surface of the vestibule chambers. The
transmembrane portion of the receptor is indicated by the yellow lines, and the negatively charged
residues (Glu and Asp) are highlighted in red. (C) The ribbon diagram of the Torpedo AChR as
viewed from the synaptic cleft (PDB entry: 2BG9) [35]. The negatively charged residues (Glu
and Asp) are highlighted in red, and some key residues involved in ACh binding are highlighted
in green. The arrangement of the subunits and the diameter of the vestibule tunnel are indicated.
(D) Schematic presentation of the pore-lining residues (filled circles). The inner shell of the
transmembrane pore is formed by the M2 helices from each subunit. The pore comprises rings
of hydrophobic residues (valine and leucine; shown in grey) and small polar residues (serine and
threonine; shown in yellow). The sequence (of a--M2) and the numbering of the residues are
shown.
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The locations of the ACh sites, the extracellular and intracellular vestibules, and
the transmembrane pore in the Torpedo AChR are shown in Figure 1.6B. The ACh
binding sites lie at the a-y (s) and a-6 subunit interfaces and are -40 A above the cell
membrane. The ion conduction pathway is formed by three connecting components: the
extracellular vestibule, the transmembrane pore, and the intracellular vestibule. Both
the extracellular and intracellular vestibules are richly lined with negatively charged
residues which are believed to stabilize the passing cations, promoting efficient
bidirectional transport of cations through the open channel. The transmembrane pore, in
which the "gate" (a hydrophobic barrier to ion permeation) is located, is lined with
several rings of hydrophobic and small polar residues [34]. Many inhibitors of the
AChR, including open-channel blockers, bind within the pore lumen [68].
Although channel states can be described simply as "open" and "closed"
depending on whether a channel conducts current flow or not, most channels adopt
multiple functional states. At least four functional states are used to describe the AChR
(Figure 1.7): the resting closed state (C), the active open state (0), the fast-onset (or
intermediate, I) and slow-onset (D) desensitized states [69]. Only the open state of the
AChR allows ion conduction. In the absence of ACh (or other agonists), the channel is
closed and non-conducting. Upon binding two molecules of agonists, the AChR
undergoes a series of conformational transitions to open the "gate" within the pore,
allowing small cations to pass. This "gating" process is fast; it occurs within
milliseconds and leads to depolarization of the cell membrane. The AChR further enters
the desensitized states, in which the agonist molecules remain bound but the gate is
closed, when exposed to a high dose or prolonged supply of agonist. The timescales of
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desensitization processes are -1-100 ms for the intermediate state and seconds or longer
for the slow state. The receptor's agonist-binding affinity is enhanced following the
transitions from the closed to the desensitized states [70].
fast transition
(ps-ms)
ACh
intermediate transition
(1-100 ms)
<I>
<0>
slow transition
(sec-min)
Figure 1.7. A simple four-state model for the microscopic transitions of the AChR. C, O, I,
and D represent closed (resting), open (active), intermediate desensitized, and desensitized states,
respectively. Only the open state allows ion conduction. The closed state has a low affinity for
agonists (10 pM to mM depending on the agonist) and the desensitized states have higher
affinities for agonists (10 nM to p.M) [70].
Figure 1.7 describes the major transitions between the closed, open, and
desensitized states of the AChR. Although it is beyond the scope of this study, it should
be noted that the exact kinetic scheme for the AChR transitions is more complex [71].
For instance, the binding of the two agonist molecules can be further considered as two
sequential steps, yielding three closed states of the AChR (unliganded, monoliganded,
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and diliganded states) in total. The AChR can open and desensitize from all of these
states, although many of the transitions may occur rarely. However, the basic scheme
described in Figure 1.7 is generally accepted and is sufficient for the electrophysiological
studies described in this thesis.
1.6. Measuring Single-Channel Currents by Patch-Clamp Techniques
The effects of a compound on a channel of interest can be investigated at the
macroscopic (whole-cell) or microscopic (single-channel) level. To gain an in-depth
understanding about the interactions of our synthesized molecules with the AChR,
single-channel analysis of AChR currents was performed. Patch-clamp recording is one
of the most powerful techniques for biophysical studies on ion channels. Detailed
mechanisms of ion permeation, channel gating, and drug interactions can be elucidated
through kinetic analysis of the currents from individual ion channels. This section
provides a brief description of the recording methods used in this thesis work. Protocols
for the instrumental setup, data acquisition, and trouble-shooting can be found in Refs. 72
and 73.
The patch-clamp setup used in our electrophysiological studies is schematically
illustrated in Figure 1.8. The AChR is heterologously expressed in human embryonic
kidney cells (HEK-293 cells). To record currents from individual AChRs, the edges of
the micropipette tip (-1 tM in diameter) need to seal off a patch of membrane from the
rest of the cell membrane. This "sealing" process electrically isolates the membrane
patch and reduces the background noise, allowing the small currents from individual
channels to be resolved. The sealing process is evaluated by measuring the electrical
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resistance of the seal between the micropipette tip and the cell membrane. An electrical
resistance of >1 GO is needed for a high quality (i.e., high signal-to-noise ratio)
recording. The use of clean, heat-polished glass micropipettes helps the formation of
tight seals. Background noise can also be reduced by coating the pipette (around the tip)
with an insulating material such as Sylgard.
oscilloscope
computer
electrode I
teste
Figure 1.8. A simple schematic illustration of the experimental setup used in the
electrophysiological studies for the synthesized molecules. The muscle-type AChR is
heterologously expressed in human embryonic kidney cells (HEK-293 cells) and the recording is
performed in the cell-attached mode. The tested molecule is supplemented in the pipette
solution. The currents are amplified by the amplifier and then digitized and stored in a desktop
computer. The amplified single-channel currents can be viewed from the oscilloscope during
recording. An additional voltage (Vhold) can be externally applied to the membrane patch via the
amplifier.
If recording is performed without detaching the membrane patch from the cell, the
recording configuration is called the "cell-attached" mode. This mode of recording is
the simplest and is the least invasive to the cell. Stable, long-lived recordings with low
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background noise can be obtained with minimal disruption of the intracellular
components associated with the membrane patch. All of the recordings performed in
this thesis work are in the cell-attached configuration. However, this recording mode
has two major disadvantages. First, the cell's resting potential (Vrest; i.e., the cell's
membrane potential in the absence of externally applied voltage) can not be measured
directly, which causes uncertainties in voltage-dependent measurements. Second, the
tested molecules can only be added to the extracellular side of the membrane, and only
one condition can be used at a time due to the difficulty in changing the pipette solution
in this recording mode.
The above-mentioned problems associated with the cell-attached configuration
can be overcome by performing recordings on excised patches. Depending on the
method of membrane excision, one can expose either the extracellular side (out-side-out
configuration) or the intracellular side (in-side-out configuration) of the membrane to the
external medium. Drugs at various concentrations can be washed in and out of the
external medium using a perfusion device. In this way, the effects of changes in the
local condition on the function of the tested channels can be studied. The Vest is zero in
the excised patches, allowing the membrane potential (Vm) to be determined from the
holding potential (Vhold, the voltage provided by the amplifier). However, excised
configurations were not used in our studies due to the lower stability of excised patches.
In our experiments, long-lived stable recordings are needed to provide enough events for
analysis. The values of Vm, albeit not perfectly precise, can be estimated in our
voltage-dependent measurements as described in Chapter Two.
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1.7. Studying Microscopic Transitions by Single-Channel Analysis
At the single-channel level, channel gating appears as step-like changes in the
current level (Figure 1.9). The kinetic behavior of the studied channel can be elucidated
by analyzing the distributions of the closed and open durations in the single-channel
recordings. This section briefly introduces background information about how the
single-channel events are analyzed in this thesis work. Depending on the blockade
behavior, recordings obtained under different conditions may need different analysis
approaches. Detailed procedures of data analysis will be described in each chapter. A
comprehensive illustration of single-channel kinetic analysis can be found in Ref. 74 and
a condensed protocol can be found in Ref. 73.
To allow the determination of statistics for closed and open dwells, the recordings
are first subjected to a computerized procedure called "idealization." Idealization is a
process that detects and categorizes single-channel events. It converts the raw recording
traces to a pairwise list of current amplitudes and dwell times. The events are
categorized depending on the observed current amplitude (Figure 1.9). When there are
multiple active channels in the patch, various conductance levels would be observed.
The current amplitude is essentially identical for each channel (if only one type of
channel is functioning), and therefore the amplitudes of the levels are multiples of the
unitary current (Figure 1.9). The list generated by idealization is then used to construct
the dwell-time distributions for each event category.
Although recordings with multiple active channels are often obtained, only those
with few simultaneously open channels are preferred for detailed kinetic analysis in order
to ensure the tractability of computational analysis. In practice, recording segments
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containing no more than two or three simultaneously open channels are used in our
studies.
3
# open
channel 0
Figure 1.9. A representative segment of single-channel recording (left) containing three
simultaneously open channels. The idealized trace is shown on the right.
Some events may not be successfully detected by idealization when the events are
brief. The response time of the recording instrument is determined by the bandwidth of
the recording setup. If the event duration is close to or shorter than the instrument's
response time, the event may be only partly resolved and the apparent amplitude and
duration would be reduced. Such an event is likely to be missed by idealization. In
our studies, the issue of missed or partially resolved events is particularly significant
when the blockade kinetics are very fast. Alternative methods, such as noise analysis,
are needed for such recordings (see Chapter Two for details).
With the idealized data in hand, one can start analyzing single-channel kinetics by
plotting the distributions of the closed and the open durations. The closed- and
open-time histograms are constructed by counting the number of durations that fall within
the time range of the selected bins. The distributions are composed of one or more
exponential components depending on the number of functional states involved. For a
more descriptive view of the exponential components, the x-axis is often plotted in the
logarithmic scale; the y-axis is the frequency (i.e., the number or the fraction of events in
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each bin) or its square root [75]. Through this transformation, each exponential
component appears as a bell-shaped asymmetrical function with the peak at the value of
its lifetime (t). The lifetime of each exponential distribution can then be visually
estimated.
Representative dwell-time histograms from a simple two-state model are shown in
Figure 1.10. The model describes transitions of a channel between the closed and the
open state, with a channel opening rate of P and a channel closing rate of a. In this
mechanism, only one non-conducting state (i.e., the closed state) is involved, so the
closed-time histogram displays a single-exponential distribution (Figure 1.10). The
mean closed time is given by the lifetime of the exponential distribution, Te, and the
channel opening rate (fl) equals 1/uc0. Analogously, the open-time histogram only
requires one exponential component for fitting, and the channel closing rate (a) is the
reciprocal of the mean open time To.
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Figure 1.10. The distributions of the closed and the open durations in a simple two-state model.
The model is shown at the top. A segment of the raw recording and its idealized trace are shown
above the histograms. Both the closed- (lower left) and the open-time (lower right) histograms
are fitted by a single-exponential distribution. C, closed state; 0, open state; fl, channel opening
rate; a, channel closing rate; T,, lifetime of the closed component; t., lifetime of the open
component. Note that the x-axes are shown in the logarithmic scales for a better visualization of
the exponential components. The opening and closing rates are 1/Tz and 1/T,, respectively.
When a channel has more than one state with the same conductance, the
dwell-time distribution for that conductance level would be composed of multiple
exponential components. For instance, in a sequential open-channel blockade
mechanism in which a blocker binds the open channel and prevents ion conduction
(Figure 1.11), both the closed and the blocked states are non-conducting. If the average
durations of the closed and blocked events are significantly different, the closed-time
histogram would contain two distinguishable exponential components. Again, the
channel opening rate (f) and the unblocking rate (k-s) can be determined from the
reciprocal of the lifetime for each component. If the blocker does not have any effects
on channel opening, the blocked component can be easily distinguished from the closed
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component. At a higher blocker concentration, more blockade events occur, leading to
an increase in the relative area of the blocked component in the closed-time histogram.
This dose-dependent feature helps the identification of the blocked component. Because
only one open state is involved in this mechanism, the open-time durations are
single-exponentially distributed.
II k+B[B] OB
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Figure 1.11. The distributions of the closed and the open durations in a sequential open-channel
blockade mechanism. The kinetic model is shown at the top. A segment of the raw recording
and its idealized trace are shown above the histograms. Single-channel currents occur as bursts
of opening events. In this specific example, the channel closing rate (a) is significantly slower
than the unblocking rate (kA). The blockade durations are therefore shorter than the closed
durations. The blockade events represent the brief gaps within a burst, and the closed events
represent the longer events that separate the bursts. The closed-time histogram (lower left)
contains two exponential components, whereas the open-time histogram (lower right) remains
single-exponentially distributed. C, closed state; 0, open state; OB, blocked state; f, channel
opening rate; k+B, blocking rate constant; [B], blocker concentration. The x-axes are shown in
the logarithmic scales for a better visualization of the exponential components.
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The example of sequential open-channel blockade illustrates the correlation
between the number of different functional states and the number of exponential
components in a dwell-time histogram. However, in some situations the lifetimes of
different states may be so close that the components cannot be easily distinguished.
Therefore, the number of exponential components in a dwell-time histogram does not
necessarily provide the total number of existing states at that conductance level.
However, it suggests the minimum number of stable states that the channel can access.
A reasonably described kinetic model is required for the fitting of the closed- and
open-time histograms. The fitting results provide the microscopic rates of channel
transitions between different states. In this thesis work, because the PEG-based
molecules are expected to function as open-channel blockers, the sequential open-channel
blockade mechanism (Figure 1.11) serves as a good starting model for our single-channel
analysis. Microscopic rate constants are estimated by maximum interval likelihood
(MIL) function implanted in the QuB program (www.qub.buffalo.edu) [76, 77]. MIL
optimizes rate constants in a given model by computing the idealized data and searching
the model parameters that maximizes the likelihood (probability) value. Details about
the analysis methods are described in the following chapters.
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Chapter Two
Structural Determinants of the Poly(ethylene glycol)-Based
Blockers for the Acetylcholine Receptor
This chapter describes the investigation of structural determinants of the proposed
poly(ethylene glycol)-based (PEG-based) open channel blockers for the muscle-type
acetylcholine receptor (AChR). A series of PEG-trimethylammonium (PEG-TMA)
conjugates were synthesized and tested by single-channel electrophysiology. The tested
PEG-TMAs vary either in the number of TMA groups attached on the PEG backbone or
in the size of PEG. Results from single-channel studies show that short PEG-TMAs
containing 4-13 ethylene oxide units both activate the AChR and block the open channel.
Having one TMA moiety per molecule is sufficient for observing blockade, and the
addition of second TMA group enhances the blocker's entry into the pore and hence the
blockade affinity. Moreover, the blockade kinetics are found to depend on spacer
length: both the blocking and unblocking rate constants (k+B and k_s, respectively)
decrease with increasing spacer length. The decrease in k+B can be quantitatively
explained by the entropic cost of polymer confinement in the transmembrane lumen,
while the decrease in k- is consistent with weak, additive non-polar interactions between
the pore interior and the PEG backbone. The work presented in this chapter serves as a
proof-of-concept study for our proposed blocker design strategy. In addition to
identifying structural determinants for PEG-based blockers, this study also provides
useful insights into the future design of kinetically tunable open-channel blockers for the
AChR.
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A significant portion of the work presented in this chapter has been published in:
Lin, W. -C., and Licht, S. (2008) Polymer-based open-channel blockers for the
acetylcholine receptor: the effect of spacer length on blockade kinetics. Biochemistry 47,
9163-9173.
2.1. Introduction
In Chapter 1.4, we proposed a new design strategy for open-channel blockers in
which a flexible polymeric backbone is used as the basic blocker scaffold. The central
hypotheses for this design are: (1) a flexible polymer is able to partition into the
transmembrane lumen of an ion channel; and (2) once inside the transmembrane lumen, a
flexible polymer adopts a conformation that maximizes favorable interactions with the
pore-lining residues. Both the blocker's ability to enter the pore and its binding within
the lumen depend on the polymer size. A larger polymer encounters a higher energy
barrier when partitioning into the pore, while it has a higher extent of interaction with the
lumen once it is fully confined. Therefore, the blockade kinetics of a polymer-based
blocker are likely to be "tunable" via backbone-length adjustment.
Poly(ethylene glycol) (PEG) serves as a promising blocker scaffold for our
design. It was previously shown to enter the pores of simple prokaryotic channels and
interrupt ion conduction [1-8]. In particular, labeling of luminal cysteines by
sulfhydryl-directed PEG reagents suggested that the partitioning of PEG molecules into
the pore of staphylococcal ac-hemolysin follows a scaling law:
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where N is the number of ethylene oxide units in the PEG chain, a is the persistence
length (i.e., the effective monomer length) of PEG, and D is the diameter of the pore [9].
The correlation applies when the PEG size, estimated as the Flory radius (RF = aN0 6, a =
3.5 A), is close to or larger than D. The scaling law describes the length dependence of
PEG's ability to enter the pore. The longer the PEG, the more free energy needed to
confine the polymer into the pore. In the single-channel analysis of ca-hemolysin
blockade by PEG, length-dependent decrease in the blocking rate constant was also
observed, consistent with the prediction made by the scaling law [7]. These
observations suggest that tuning the blocking rate constant by PEG size is feasible.
Although PEGs block prokaryotic channels, the pore-binding affinities of PEGs
are weak. The effects of PEGs on channel currents were mostly reported with very high
concentrations of PEGs (e.g., 15% w/w) [1-6, 8]. One possible explanation for PEG's
low blockade affinities is the lack of electrostatic interactions between the neutral
polymers and the transmembrane electric field. It is generally recognized that both
cationic and hydrophobic moieties are required for open-channel blockers of
cation-selective ion channels such as nicotinic acetylcholine receptor (AChR), glutamate
receptors, and potassium channels [10]. The charged moiety is proposed to provide
electrostatic interaction with the transmembrane electric field. The structure of
representative open-channel blockers of the AChR are shown in Figure 2.1. These
blockers all have either a quaternary ammonium (QA) group (a permanently charged
moiety) or an amino group that is protonated at physiological pH. Therefore, installing
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one or more charged moieties on the PEG backbone is likely to enhance the polymer's
blockade potency.
H
HO,,. H
H 3CO H
N
quinidine
O (CH2 )nCH3
N
PIP series
(n = 0-5)
HN O HN /
bupivacaine MK-801
H IN\R
IEM-series
phencyclidine (PCP)
QX-222 (R = CH 3)
QX-314 (R = C2H5 )
Figure 2.1. Structure of some previously characterized open-channel blockers for the AChR.
Note that the molecules have either an amino group (top) or a quaternary ammonium group
(bottom). The remaining part of each molecule is fairly hydrophobic.
The size of the polymer backbone is also an important structural determinant for
the PEG-based blockers. A proper PEG length would be short enough to reduce the
entropic cost for entering the pore but long enough to provide substantial interactions
with the pore interior. Within a proper range of PEG size, blockade would be
observable, and the rates of blocker association and dissociation are expected to be
length-dependent.
In this thesis work, the proposed design strategy was tested by developing
open-channel blockers for the AChR. The AChR is a non-selective cation-permeant
channel, and the majority of its open-channel blockers contain either an amino or a QA
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group (Figure 2.1). Therefore, we first studied whether the attachment of
positively-charged moieties to PEG allows the resulting molecule to block the AChR.
The smallest QA moiety, trimethylammonium, was chosen for the proof-of-concept
experiments. A bivalent (la) and a monovalent (Ib) PEG-trimethylammonium
(PEG-TMA) conjugate (Scheme 2.1) were synthesized from a short PEG (tetra(ethylene
glycol)) and were tested by single-channel electrophysiology. Both compounds cause
fast blockade on the open AChR currents, while the parent PEG does not exhibit the same
effect, supporting the design strategy.
We then studied the effects of PEG size on blockade kinetics. Bivalent
PEG-TMA conjugates containing 4, 8, and 13 ethylene oxide units (compounds la, 2,
and 3, Scheme 2.2) function as both agonists and blockers of the AChR. Kinetic
analysis of single-channel events indicates that both the blocking and unblocking rate
constants decrease with increasing PEG length. The decrease in blocking rate constant
appears to result from the entropic cost of partitioning the polymer into the
transmembrane lumen, while the drop in unblocking rate constant appears to be
associated with weak, additive interactions between PEG and the pore interior. The
results support our design strategy and provide insights into the future design of
kinetically tunable channel blockers.
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Scheme 2.1. Synthesis of Bivalent and Monovalent PEG-TMA Conjugates for
Testing the Design Strategy.
I' I-a (53%)
2
(1) MsCI, TEA, CH2 CI2  2
HO -OO OH
2 (2) Nal, CH 3CN, 80 C
HO 
_O O I I-a' (22%)
2
2 i
NMe 3 (aq)
HO 0 " I lb (91%)
2
2.2. Materials and Methods
2.2.1. Synthesis of PEG-TMA Conjugates
General Methods. Chemicals were purchased from Aldrich (Milwaukee, WI) as
reagent grade and were used as supplied. Anhydrous methylene chloride and
acetonitrile were packed in Sure/SealTM bottles and were transferred under nitrogen with
a syringe. 'H and 13C NMR spectra were recorded on a Varian Mercury 300
spectrometer. Chemical shifts (8) were calibrated to the residual solvent peak and were
expressed in parts per million (ppm). Coupling constants (J) were reported in Hz.
High resolution electrospray mass spectra were obtained by a Bruker Daltonics APEXIV
4.7 Tesla FT-ICR mass spectrometer. Analytical thin-layer chromatography (TLC) was
performed using silica 60 F254-precoated glass plates (EMD Chemicals Inc., Gibbstown,
NJ). Compounds were visualized by staining with aqueous potassium permanganate.
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Normal-phase column chromatography was carried out on Merck® silica gel 60 (70-230
mesh, Aldrich).
Synthesis of precursors (I-a and I-a') for Bivalent and Monovalent PEG-TMA
Conjugates. Tetra(ethylene glycol) (1.0 mL, 5.8 mmol) was dissolved in anhydrous
CH2C12 (20 mL) at 0 "C under an atmosphere of dry N2. Triethylamine (1.6 mL, 11.6
mmol) was added, followed by dropwise addition of methanesulfonyl chloride (676 /tL,
8.7 mmol). The reaction was allowed to warm to ambient temperature and was stirred at
25 C for 3 h. The mixture was filtered, and the filtrate was concentrated by rotary
evaporation and dried under high vacuum. The residue and sodium iodide (2.61 g, 17.4
mmol) were suspended in anhydrous CH3CN (40 mL), and the mixture was stirred at 80
0C for 16 h. The mixture was filtered, and the precipitate was washed with ice-cold
CH 3CN. The combined filtrate was concentrated, re-suspended in EtOAc (50 mL), and
filtered again. The filtrate was concentrated by rotary evaporation and purified by silica
gel chromatography (1:5 hexanes:EtOAc 4 9:1 EtOAc:MeOH) to give I-a (1.27 g, 53%)
and I-a' (0.38 g, 22%) as light yellow oil.
I-a: TLC (1:5 hexanes: EtOAc) Rf 0.63; 'H NMR (CDC13, 300 MHz): 8 3.77 (t, J = 6.9
Hz, 4H, -CH 2CH2I), 3.72-3.64 (br s, 8H), 3.27 (t, J = 6.9 Hz, 4H, -CH2I); 13C NMR
(CDC13, 75 MHz): 8 71.9, 70.7, 70.2, 3.0; HRMS-ESI (m/z) calcd for C8H1612NaO3 [M +
Na]+: 436.9081; found: 436.9086.
I-a': TLC (9.5:0.5 EtOAc: MeOH) Rf 0.25; 'H NMR (CD 30D, 300 MHz): 8 3.74 (t, J=
6.6 Hz, 2H, -CH 2CH2I), 3.69-3.62 (m, 10OH), 3.59-3.54 (m, 2H), 3.31 (t, J= 6.6 Hz, 2H,
-CH 2I); 13C NMR (CDC13, 75 MHz): 8 73.8, 73.2, 71.8, 71.7, 71.6, 71.2, 62.4, 3.3;
HRMS-ESI (m/z) calcd for C8H17INaO4 [M + Na]+: 327.0064; found: 327.0052.
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Synthesis of Bivalent PEG-TMA (la). Diiodide I-a (396 mg, 0.96 mmol) was
dissolved in CH 3CN (3 mL) and was added to an aqueous solution of trimethylamine
(25-27 wt. %, 12 mL). The reaction mixture was stirred at 25 C for 17 h and was
concentrated by rotary evaporation. The residue was dissolved in ethanol, concentrated
by rotary evaporation, and dried under high vacuum to give a colorless viscous syrup. A
colorless solid formed slowly while the syrup was stored in a dessicator filled with dry
N2. The solid was removed, washed with diethyl ether, and dried under high vacuum to
give la as a white powder (487 mg, 96%). 'H NMR (CD 30D, 300 MHz): 8 3.96 (m,
4H, -CH 2NMe3 ), 3.72-3.64 (m, 12H), 3.27 (s, 18H, -N(CH 3)3+); 13C NMR (CDC13 , 75
MHz): 6 71.5, 71.5, 67.0 (t, J = 3.1 Hz), 66.1, 55.2 (t, J = 3.8 Hz); HRMS-ESI (m/z)
calcd for C14H34IN 20 3 [M - I]+: 405.1609; found: 405.1595.
Synthesis ofMonovalent PEG-TMA (ib). Monoiodide I-a' (317 mg, 1.04 mmol)
was dissolved in an aqueous solution of trimethylamine (25-27 wt. %, 10 mL). The
reaction mixture was stirred at 25 "C for 19 h and was concentrated by rotary
evaporation. The residue was dissolved in ethanol, concentrated by rotary evaporation,
and dried under high vacuum to give a colorless viscous syrup. A colorless solid
formed slowly while the syrup was stored in a dessicator filled with dry N2. The solid
was removed, washed with diethyl ether, and dried under high vacuum to give lb as a
white powder (342 mg, 91%). 'H NMR (CD30OD, 300 MHz): 8 3.97 (m, 2H,
-CH 2NMe 3 ), 3.74-3.60 (m, 12H), 3.57 (m, 2H), 3.25 (s, 9H, -N(CH 3 )3 ); 13C NMR
(CDC13, 75 MHz): 6 73.8, 71.6, 71.5, 71.4, 71.4, 67.0 (t, J= 3.2 Hz), 66.1, 62.3, 55.2 (t, J
= 3.9 Hz); HRMS-ESI (m/z) calcd for C1IH 26NO4 [M - I]+: 236.1856; found: 236.1847.
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Scheme 2.2. Synthesis of Bivalent PEG-TMA Conjugates for Studying Length
Dependences of Blockade Kinetics and Affinity.
(1) MsCI, TEA, CH 2CI2
n (2) Nal, CH3CN, 80 C
I-b, n = 6 (83%)
I-c, n - 11
I-d, n - 20 (82%)
I-e, n - 77 (85%)
I-f, n - 227 (72%)
NMe3 (aq) or NMe 3/EtOH ® G I B
2, n = 6 (-quantitative)
3, n - 11 (-quantitative)
4, n - 20 (95%)
5, n - 77 (86%)
6, n - 227 (95%)
General Procedure for the Preparation of Diiodides (I-b, I-c, and I-d). The
starting material (octa(ethylene glycol), PEG-600, or PEG-1000, -1 mmol, 1 equiv.) was
dissolved in anhydrous CH2C12 under an atmosphere of dry N2. Triethylamine (560 #L,
4 mmol) was added, followed by dropwise addition of methanesulfonyl chloride (230 ItL,
3 mmol). The reaction was allowed to warm to ambient temperature and was stirred at
25 "C for 3-5 h. The mixture was diluted with CH 2CI 2 (40 mL for I-b and I-c, 80 mL
for I-d) and was washed with 1 N HCI (2 x 50 mL), H20 (50 mL), and brine (2 x 50 mL).
The organic phase was dried over anhydrous Na2 SO 4, concentrated by rotary evaporation,
and dried under high vacuum to give crude dimesylate. The obtained dimesylate and
sodium iodide (750 mg, 5 mmol) were suspended in anhydrous CH3CN (20-30 mL)
under an atmosphere of dry N2. The mixture was stirred at 80 "C for 12-15 h, cooled to
room temperature, and then filtered. The precipitate was washed with CH 3CN, and the
- 55 -
combined filtrate was concentrated by rotary evaporation. The residue was dissolved in
CH2C12 (50 mL for I-b and I-c, 100 mL for I-d), washed with 0.2 M Na2S20 3 (2 x 50
mL), H20 (50 mL), and brine (2 x 50 mL). The organic phase was dried over
anhydrous Na2SO 4, concentrated by rotary evaporation, and purified by silica gel
chromatography to give the corresponding diiodide.
I-b: Diiodide I-b was synthesized from octa(ethylene glycol) (363 mg, 0.98 mmol in 5
mL anhydrous CH2C12 ). Purification by silica gel chromatography (1:9 MeOH:EtOAc)
gave I-b as a pale yellow liquid (479 mg, 83% over two steps). TLC (1:9
MeOH:EtOAc) Rf 0.50; 'H NMR (CDC13, 300 MHz): 6 3.73 (t, J = 7.0 Hz, 4H,
-CH 2CH2I), 3.67-3.58 (br, 24H), 3.24 (t, J= 7.0 Hz, 4H, -CH2I); 13C NMR (CDC13, 75
MHz): 6 71.8, 70.5, 70.4 (br, PEG backbone), 70.0, 2.9; HRMS-ESI (m/z) calcd for
C16H3212NaO7 [M + Na]+: 613.0130; found: 613.0145.
I-c: Diiodide I-c was synthesized from PEG-600 (586 mg, -0.98 mmol in 5 mL
anhydrous CH 2CL2). The iodination products were separated by silica gel
chromatography (5:95 MeOH:CHCl3). Because the starting material was a mixture of
oligomers, only the fractions containing the desired backbone size (n - 11 as judged by
1H NMR) were collected (363 mg, pale yellow liquid). TLC (5:95 MeOH:CHCl 3) Rf
-0.25; IH NMR (acetone-d 6, 300 MHz): 6 3.74 (t, J= 6.6 Hz, 4H, -CH 2CH2I), 3.66-3.58
(m, 8H), 3.60-3.56 (m, 36H), 3.34 (t, J= 6.6 Hz, 4H, -CH2I); 13C NMR (acetone-d 6, 75
MHz): 8 72.6, 71.4, 71.3 (br, PEG backbone), 70.9, 4.7.
I-d: Diiodide I-d was prepared from PEG-1000 (Mn 950-1050, 1.0 g, -1 mmol in 20 mL
anhydrous CH2C12). The crude product was purified by silica gel chromatography (8:92
MeOH: CHC13) to give compound I-d as a white wax (1.0 g, -82% over two steps). 'H
-56-
NMR (CDCl3, 300 MHz): 5 3.74 (t, J= 6.9 Hz, 4H, -CH 2CH2I), 3.8-3.4 (br, -80H), 3.24
(t, J = 6.9 Hz, 4H, -CH2I); '3C NMR (CDC13, 75 MHz): 8 71.8, 70.6-70.4 (PEG
backbone), 70.1, 2.9.
Synthesis of Diiodide I-e. PEG-3400 (5.0 g, 1.5 mmol) was dissolved in
anhydrous CH 2C 2 (15 mL) under an atmosphere of dry N2. Triethylamine (547 !LL, 4.1
mmol) was added, followed by dropwise addition of methanesulfonyl chloride (273 IL,
3.5 mmol). The reaction was allowed to warm to ambient temperature and was stirred at
25 °C for 4 h. The mixture was diluted to 100 mL with CH 2C12 and was washed with 1
N HCI (2 x 100 mL), H20 (100 mL), and brine (2 x 100 mL). The organic phase was
dried over anhydrous Na2SO4, concentrated by rotary evaporation, and dried under high
vacuum to give crude dimesylate as a colorless syrup. Precipitation of the crude product
in diethyl ether provides PEG dimesylate as a white powder (4.8 g, 92%). A portion of
the purified dimesylate (2.0g, 0.55 mmol) and sodium iodide (824 mg, 5.5 mmol) were
suspended in anhydrous CH 3CN (20 mL) under an atmosphere of dry N2. The mixture
was stirred at 80 "C for 5 h, cooled to room temperature, and then diluted to 150 mL with
CH 2CL2. The solution was washed with 0.2 M Na2S203 (2 x 50 mL), H20 (50 mL), and
brine (2 x 50 mL). The organic phase was dried over anhydrous Na2 SO 4, concentrated
by rotary evaporation, and purified by precipitation in diethyl ether to give I-e as a pale
yellow powder (1.9 g, 92%; 85% over two steps). 'H NMR (CDCl3, 300 MHz):
6 4.0-3.3 (br, -300H), 3.23 (t, J= 6.9 Hz, 4H); 13C NMR (CDC13, 75 MHz) 6 71.8, 70.5,
70.4 (br, PEG backbone), 70.1, 2.9. [Note: IH NMR assignment for the dimesylate
(CDC13, 300 MHz): 68 4.28 (m, 4H), 3.8-3.3 (br, -300H), 3.0 (s, 6H); '3C NMR
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assignment for the dimesylate: (CDC13, 75 MHz) 8 70.2 (br, PEG backbone), 69.0, 68.6,
37.3.]
Synthesis of Diiodide I-f Diiodide I-f (3.9 g of white powder, 72% over two
steps) was synthesized from PEG-10000 using the protocol described for I-e. 'H NMR
(CDCl3, 300 MHz): 8 4.0-3.3 (br, -900H), 3.19 (t, J= 6.6 Hz, 4H); 13C NMR (CDC13) 6
71.7, 70.4 (br, PEG backbone), 70.0, 2.8. [Note: 'H NMR assignment for the
dimesylate (CDCl3, 300 MHz): 8 4.35 (m, 4H), 4.2-3.2 (br, -900H), 3.06 (s, 6H); 13C
NMR assignment for the dimesylate: (CDC13, 75 MHz) 8 70.2 (br, PEG backbone), 69.0,
68.7, 37.4.]
General Procedure for the Preparation of Bivalent PEG-TMA Conjugates (2, 3,
and 4). The starting material (I-b, I-c, or I-d, 0.4-0.6 mmol) was dissolved in CH 3CN
(2 mL) and was added to an ethanolic (31-35 wt. %) or aqueous (25-27 wt. %) solution
of trimethylamine (6 mL). The mixture was stirred at 25 C for 8-18 h and was
concentrated by rotary evaporation. The residue was dissolved in ethanol, concentrated
by rotary evaporation, and dried under high vacuum to give the corresponding product as
a highly viscous syrup.
Compound 2: The bis(trimethylammonium) salt 2 was prepared from diiodide I-b (353
mg, 0.60 mmol). The product was obtained as a pale yellow, highly viscous syrup after
the removal of solvent and volatiles (425 mg, quantitative). 'H NMR (CD 30D, 300
MHz): 6 3.97 (m, 4H, -CH 2NMe 3 ), 3.72-3.58 (m, 28H), 3.24 (s, 18H, -N(CH 3)3 ); 13C
NMR (CD 30D, 75 MHz): 8 71.7 (3 peaks), 71.6, 71.5, 71.4, 67.1, 66.1, 55.0 (t, J= 3.9
Hz); HRMS-ESI (m/z) calcd for C22H50IN20 7 [M - I]+: 581.2657; found: 581.2649.
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Compound 3: The bis(trimethylammonium) salt 3 was prepared from diiodide I-c (344
mg, -0.42 mmol). The product was obtained as a pale yellow, highly viscous syrup
after the removal of solvent and volatiles. The obtained product weight (410 mg) was
slightly higher than the predicted quantitative yield (394 mg), presumably due to the
absorption of moisture by the highly hygroscopic product (impurity peaks were not found
in the 1H NMR spectrum). 'H NMR (CD 30D, 300 MHz): 8 3.97 (m, 4H, -CH 2NMe3+),
3.8-3.5 (m, -48H), 3.24 (s, 18H, -N(CH 3)3+); 3C NMR (CD 30D, 75 MHz): 5 71.7 (br,
PEG backbone), 71.5, 71.4, 67.1, 66.1, 55.1; HRMS-ESI (m/z) calcd for C32H701N20 12
[M - I]+: 801.3968; found: 801.3934. [Note: Peaks corresponding to [M - I]+ and [M -
2I]2+ of a group of congeners (n = 7 to 15) were observed, suggesting that the product is a
mixture of congeners having an average backbone size of 13 ethylene glycol units (i.e., n
= 11 in Scheme 2.2).]
Compound 4: The bis(trimethylammonium) salt 4 was prepared from diiodide I-d (438
mg, -0.36 mmol). A viscous syrup was obtained after the removal of solvent and
volatiles, and the syrup slowly turned into a pale-yellow, hygroscopic wax (457 mg,
-95%) under an atmosphere of dry N2. 1H NMR (CD 30D, 300 MHz): 5 3.98 (m, 4H,
-CH 2NMe3+), 3.8-3.5 (br, -84H), 3.23 (s, 18H, -N(CH 3)3+); 13CNMR (CD 30D, 75
MHz): 8 71.8-71.4 (PEG backbone), 71.4 (2 peaks), 67.0 (t, J= 3.1 Hz), 66.1, 55.1 (t, J
3.9 Hz).
Synthesis of Bivalent PEG-TMA (5). Diiodide I-e (375 mg, 0.1 mmol) was
dissolved in an aqueous solution of trimethylamine (25-27 wt. %, 5 mL). The mixture
was stirred at 25 "C for 24 h and was concentrated by rotary evaporation. The residue
was dissolved in a small amount of methanol, and the PEG-TMA (5) was obtained as a
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white powder (332 mg, 86%) by precipitation in diethyl ether. 'H NMR (CD 30D, 300
MHz): 8 3.98 (m, 4H, -CH 2NMe 3+), 3.9-3.3 (br, -300H), 3.26 (s, 18H, -N(CH 3)3+).
Synthesis of Bivalent PEG-TMA (6). Diiodide I-f (3.4 g, 0.33 mmol) was
dissolved in a small amount of CH 3CN and was added to an aqueous solution of
trimethylamine (25-27 wt. %, 25 mL). The mixture was stirred at 25 0C for 18 h and
was concentrated by rotary evaporation. The residue was dissolved in a small amount of
methanol, and the PEG-TMA (6) was obtained as a white powder (3.2 g, 95%) by
precipitation in diethyl ether. 'H NMR (CD 30D, 300 MHz): 8 3.99 (m, 4H,
-CH 2NMe3+), 3.9-3.3 (br, -900H), 3.23 (s, 18H, -N(CH 3)3+).
2.2.2. Plasmids and Channel Expression
The cDNA clones of adult mouse muscle AChR subunits (a, 8, e) in the vector
pRBG4 were generously provided by Professor Anthony Auerbach (SUNY Buffalo,
Buffalo, NY) [11]. The a subunit contains the previously described V433A background
mutation, which does not affect gating kinetics and is referred to as wild-type [11].
Plasmids were transiently transfected into HEK-293 human embryonic kidney cells
(ATCC CRL-1573) by calcium phosphate precipitation [11]. In brief, HEK-293 cells
were maintained in Dulbecco's Minimum Essential Media (DMEM) (Invitrogen,
Carlsbad, CA) supplemented with 10% Fetal Bovine Serum (FBS) (Invitrogen) at 37 °C
and 5% CO 2 . Cells were plated 24 h before transfection to reach a confluence of
40-60%. A total of 3.5 gg DNA per 35 mm culture dish in the ratio of 2:1:1:1 (a:.p:JC)
was used. The medium was changed 24 h after the addition of DNA, and patch-clamp
recordings were performed 20-36 h thereafter.
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2.2.3. Patch-Clamp Recording
Single-channel currents from adult mouse muscle AChRs were recorded using
patch-clamp techniques in the cell-attached configuration. A brief introduction of this
technique can be found in Chapter 1.5. Unless otherwise specified, a holding potential
(Vhold) of +70 mV was applied to the pipette tip during recording. Patch pipettes were
pulled from borosilicate capillary tubes (World Precision Instruments, Sarasota, FL) and
were coated with Sylgard 184 (Dow Coming, Midland, MI). Pipette tips were typically
0.5-1 p.m in diameter. The extracellular solution (bath solution) comprised (mM):
137.9 NaCl, 8.1 Na2HPO4, 2.7 KC1, 1.5 KH2PO 4, 0.9 CaC12, and 0.5 MgC12 (pH 7.4).
The pipettes were filled with the bath solution supplemented with the small molecule of
interest. The currents were amplified (Axopatch 200B, Axon Instruments, Foster City,
CA), low-pass filtered at 10 kHz, and digitized at 20 kHz (NI 6040 E Data Acquisition
Board, National Instruments, Austin, TX). Data were recorded directly to a desktop PC
hard drive using the QuB software (www.qub.buffalo.edu).
2.2.4. Data Analysis
General Methods. Kinetic analysis of single-channel currents was carried out
using the QuB suite [12, 13]. Current records from membrane patches with relatively
low channel activity (defined here as patches containing no more than three channels
open simultaneously at any point during the record) were used for analysis. The
currents were idealized using the segmented k-means (SKM) hidden Markov algorithm at
full bandwidth (10 kHz) [14]. Kinetic modeling of the idealized intervals was
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performed using the maximum interval likelihood (MIL) method [12, 13] with a dead
time of 0.125 ms. The values of apparent mean open time (to) were calculated by MIL.
Estimation of the Membrane Potential for Voltage-Dependent Measurements.
The membrane potential (Vm) at a given holding potential (Vhold) was estimated as Vrst -
Vhold, where Vret (resting potential) is the membrane potential in the absence of externally
applied voltage. The estimation is based on the previously reported current-voltage
relationship of the AChR, in which the current amplitude of the AChR changes linearly
with Vm and the reversal potential (the transmembrane voltage at which the direction of
current starts to reverse) is 0 mV [15]. Vrest was estimated by plotting the amplitude of
the open-state peak (estimated by Gaussian fitting of the amplitude histogram) as a
function of Vhold. The plot is well fitted by least-squares linear regression, giving the
slope as the single-channel conductance of the AChR and the x-intercept as Vrest. The
value of single-channel conductance estimated from this method (60-70 pS) is in good
agreement with the reported value for the adult-type AChR (65 pS) [15]. In our
recordings, the estimated Vrest varies from cell to cell, ranging from -20 to -60 mV.
Analysis of Fast Blockade Kinetics (Partially Resolved Blockade Events). In the
presence of la or ib, the single-channel currents represent bursts of brief opening events
separated by short gaps (Figures 2.2 and 2.3A). In most data records, the short gaps
within bursts of openings could be partially resolved at our recording bandwidth, and a
fast component (lifetime < 1 ms) was found in the closed-time distribution. The time
constant (T) and the area (a) of this fast component and its closest slow component were
used to calculate the critical time constant (7r) for defining bursts of openings [16].
Bursts of openings were defined using r7 as the shortest gap duration between two bursts.
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At 1 mM la, the events were too fast to be resolved, and the fast component could not be
found in the closed-time distribution. A fixed 7r (1 ms) was used to define bursts in
such files. Recording segments containing 1500-15000 single-channel opening bursts
were chosen for further analysis.
Power spectra for single-channel records were obtained using the QuB suite.
The net power spectrum, which is a measurement of the excess current noise when the
channel is equilibrating between open and blocked states, was plotted by subtracting the
spectral density function of the background noise from that of the open channels [17].
The resulting net spectrum (plotted within 500-10000 Hz) was fitted to a Lorentzian
distribution:
S(f) = 0)2 x f 2  (2)S(f)= (2)f2 + f2
where S(f) is the spectral density function, f is the frequency, and fe is the half-amplitude
frequency (i.e., corne frequency).
For the analysis of voltage-dependent blockade by la and ib, fractional blockade
was defined by comparing the mean current amplitude (imean) and the current amplitude of
the unblocked state (iunblock) for the bursts [17]. The value of imean was obtained directly
from SKM. The value of iunblock was defined as the amplitude corresponding to the
"open state" peak in the amplitude histogram plotted for bursts of single-channel
openings (see Fig. 2.4C for representative histograms).
Analysis of Slower Blockade Kinetics (Resolved Blockade Events).
Single-channel events recorded in the presence of compound 2 or 3 were resolved well by
our recording bandwidth, allowing direct fitting of the idealized data by MIL [12, 13].
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At most of the tested concentrations and voltages, the closed- and open-time histograms
were well fitted using the simple sequential model for open-channel blockade:
P kB[B]C O B] OB
a k-B (3)
where C, 0, and OB refer to the closed, open, and blocked states of the AChR, and /, a,
k+B, k-B, and [B] refer to channel opening rate, channel closing rate, blocking rate
constant, unblocking rate constant, and blocker concentration, respectively. At higher
blocker concentrations (mostly higher than 200 tM) or when the channel activity was
very low, a third closed state was often required for reasonable fitting. For compounds
2 and 3, the values of a, , kaB[B], and kB were obtained directly from MIL fitting.
Analysis of Single-Channel Currents Evoked by Compounds 4-6. For
compounds 4-6, the closed- and open-time histograms were well fitted by a two-state
model:
C o-
a (4)
where C and O refer to the closed and open states of the AChR, and 8 anda are channel
opening rate and channel closing rate, respectively.
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2.3. Results
2.3.1. Activation and Blockade by Short PEG-TMA Conjugates
Synthesis of Bivalent and Monovalent PEG-TMA Conjugates (la and ib). To
investigate whether the attachment of a charged moiety to PEG is required for causing
open-channel blockade of the AChR, a bivalent (la) and a monovalent (Ib) prototype
molecule were first tested using patch-clamp electrophysiology. Both molecules were
synthesized from tetra(ethylene glycol) (Scheme 2.1), but they differ in the number of
QA groups attached. In the bivalemt molecule (la), both ends of PEG are converted to
trimethylammonium groups, while one of the parent PEG's terminal hydroxyl groups is
retained in the monovalent homologue (ib).
In brief, la and lb were synthesized by SN2 substitution of di- and monoiodide
derivatives of tetra(ethylene glycol) (Scheme 2.1). Tetra(ethylene glycol) was treated
with 1.5 equivalent of methanesulfonyl chloride to produce a mixture of di- and
monomesylate derivatives. Replacing the terminal mesylate groups by iodide ions
provided the iodide derivatives (I-a and I-a'). Purified I-a and I-a' each reacted with
trimethylamine to give PEG-TMA conjugates la and lb.
Characterization of Single-Channel Currents Induced by la and lb. Several
cationic organic compounds containing one or more trimethylammonium groups exhibit
both agonist and blocker activities [17-19]. For instance, decamethonium and
phenylpropyltrimethylammonium (PPTMA) have been characterized as weak agonists of
the AChR that also have moderate affinities for the open pore (Kd values are 9-20 and
90-160 rM, respectively) [19]. These compounds cause a decrease in the apparent
mean open time (To) in a dose-dependent manner. Smaller compounds, such as
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acetylcholine (ACh) or carbamylcholine (CCh), exhibit fast blockade kinetics [17, 18].
Blockade by these small molecules leads to bursts of single-channel currents (which are
composed of brief, partially resolved conducting and blockade events) and reduced mean
current amplitude. PEG-TMA conjugates la and lb are therefore likely to act
analogously to these previously characterized agonists/blockers.
To determine whether la and lb act as agonists and/or channel blockers, we
measured single-channel currents of the AChR in the presence of each compound at a
concentration of 100 ptM (Figure 2.2). AChR currents were also measured under a
control condition: 100 pM of tetra(ethylene glycol) and 200 pM of
tetramethylammonium (TMA) chloride. Under the control condition, step-like
single-channel currents of the AChR were observed and the open-state current noise was
low. The apparent mean open time (to = 0.76 ± 0.32 ms; mean ± S.D.) under the control
condition is close to the mean open duration of the AChR stimulated by TMA (0.66 ms)
[20] and PPTMA (0.88 ms) [19], suggesting that the open durations of the channel are not
abbreviated by free tetra(ethylene glycol). Both the low open-state noise and the
unaffected value of -o indicate that free PEG itself, at 100 pM, does not cause measurable
blockade of the open AChR.
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<100 pM PEG + 200 LpM TMA>
<100 pM bivalent PEG-TMA (Ia)>
<100 pM monovalent PEG-TMA (1 b)>
8 pA
10 ms
Figure 2.2. Single-channel AChR currents stimulated by tetramethylammonium (with free PEG)
or the PEG-TMA conjugates (la and Ib). Representative recording segments at 100 AM are
shown (holding potential = +70 mV). Idealized traces are shown on top of each recording
segments. Many of the brief gaps within the bursts of currents at 100 gM la/lb are missed by
idealization. Currents are presented as upward deflections. Note that "TMA" stands for
tetramethylammonium and trimethylammonium, respectively, in control and PEG-TMA. The
PEG used in the control and each conjugate contains four ethylene oxide units.
As shown in Figure 2.2, both la and lb are capable of stimulating AChR
openings, but the currents appear to be different from those under the control condition.
At 100 gM of la/lb, bursts of flickering events were observed. Many of the brief gaps
within bursts were only partially resolved and were missed by idealization. As a
consequence, the open-state noise was apparently higher than that under the control
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condition, and the mean current amplitude was lower. These features are indicative of
fast open-channel blockade by the PEG-TMA conjugates.
Concentration Dependence of Blockade by la and lb. Several open-channel
blockers of the AChR, such as tetraethylammonium (TEA) and piperazinium (PIP)
derivatives, are known to cause fast open-channel blockade [21, 22]. To further
characterize the blockade mechanism, we measured single-channel currents at various
concentrations of la/lb (Figure 2.3). When blocking and unblocking processes are fast,
blocker binding may, counter-intuitively, prolong bursts of channel openings, with higher
concentrations of blocker producing longer bursts [23]. The burst-like currents arise
from repeated transient interruptions of ion conduction by blockade events when a
channel is open. The duration of a burst is therefore the sum of the time that an open
channel stays unblocked and the time that it is occupied by a blocker. If blocker binding
does not accelerate the closure of an open channel, an increase in blocker concentration
will lead to a higher frequency of blockade, resulting in a longer mean burst length.
Experimentally, as the concentration of la/lb is increased, the frequency of brief
interruptions of open-state currents, the reduction in mean conductance, and the mean
duration of single-channel bursts all increase. As shown in Figure 2.3B, both la and lb
cause a concentration-dependent increase in the mean burst duration (Tburst), which is
consistent with the prediction for fast open-channel blockade.
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Figure 2.3. Concentration-dependent blockade by la and lb. (A) Representative recording
traces at various concentrations of la (holding potential = +70 mV). Currents are presented as
upward deflections. (B) Mean burst length (7Tburst) as a function of blocker concentration. (C)
Representative net power spectra of current noise. Data are fitted by a single Lorentzian
distribution, fe, half-amplitude frequency (corner frequency). (D) Corner frequency as a
function of blocker concentration. Data are fitted by least-squares linear regression. The slope
and y-intercept correspond to k+/2xt and k/2t, respectively. Error bars represent standard
deviations of triplicates.
Because blocking and unblocking events are too fast to be measured directly, blocking
and unblocking rate constants were estimated through noise analysis, which has
previously been used to study rapid channel blockade [17]. When the concentration of
la/lb increases, a decrease in the mean amplitude of the open-state current, accompanied
by an increase in current noise, is observed (Figure 2.3A). Rapid blocking and
unblocking events manifest themselves as noise in open-channel currents, allowing
blocking and unblocking rate constants to be determined from the power spectra of open
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channel noise (Figures 2.3C and 2.3D). The construction of the net power spectrum is
described in Chapter 2.2.4. The net power spectrum of each recording was fitted by a
Lorentzian distribution (Equation 2 in section 2.2.4), and the blocking and unblocking
rate constants were calculated from the linear dependence off, (i.e., the half-amplitude
frequency for the net power spectrum) on blocker concentration [17]:
f = k_ k+B) [B] (5)
where k+B and k-B are blocking and unblocking rate constants, respectively. The values
of k+B and k-s for la are calculated to be 168 ± 17 tM-ls -' and (3.53 ± 0.23) x 104 s -1,
respectively (Figure 2.3D), giving the equilibrium dissociation constant (Kd = k-B / k+B)
as 210 ± 25 jtM. For ib, k+B, k-s and Kd are 37 + 15 tMl's', (3.01 + 0.40) x 104 s-1,
and 848 ± 358 jtM, respectively. The rate constants are of the same order of magnitude
as those of open-channel blockade by ACh, CCh, and PIP [17, 22]. A comparison of
blockade kinetics between la and lb shows that la binds the open AChR approximately
5-fold faster than lb does. There is, however, only a marginal difference in the
unblocking rate constant, leading to a 4-fold decrease in blocker's affinity.
Voltage Dependence of Blockade by la and lb. To examine whether la and lb
target the transmembrane lumen of the AChR, blockade was measured at various
membrane potentials. If la and lb bind the open pore from the extracellular side,
blockade would be favored at more negative membrane potentials. As predicted,
channel blockade by la/lb (measured as fractional blockade; see section 2.2.4) is
sensitive to the alterations in the membrane potential (Fig. 2.4). At 100 AM la,
fractional blockade increases about 2.5-fold when the membrane potential goes from
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approximately -70 to -130 mV, suggesting that the positively charged la is attracted by
the transmembrane electric field. This observation is consistent with the prediction for
blockade from the extracellular side. At membrane potentials more negative than -130
mV, hyperpolarization causes a decrease in AChR blockade, presumably due to the
permeation of the blocker into the cell [24, 25]. Fractional blockade by lb is also
sensitive to membrane potential changes (Figure 2.4B). Consistent with the
observations for k+B and K, the decreased valency of lb is associated with more than a
2-fold difference in fractional blockade. Comparing fractional blockade at 100 pM la
and 200 p.M ib, la remains a stronger blocker over the less hyperpolarized membrane
potentials (-70 to -130 mV), indicating that the additional QA group of la might have
other effects on AChR blockade in addition to doubling the effective blocker
concentration.
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Figure 2.4. Voltage-dependent blockade by la and lb. (A) Representative recording traces at
various membrane potentials (100 jtM la). Currents are presented as upward deflections. (B)
Fractional blockade as a function of membrane potential. One representative patch out of
triplicates is shown for each condition. (C) Representative amplitude histograms (plotted for
single-channel bursts, 100 jiM la) at various membrane potentials. Symbol "O" indicates the
"open-state" peak.
The voltage dependence of fractional blockade can be used to estimate the
binding site of a charged blocker in the transmembrane region. The Woodhull model
has been applied to study the voltage dependence of fast blockade in both whole-cell [26]
and single-channel [18, 22] currents. At the single-channel level, bandwidth limits of
recording devices lead to partially resolved blocking/unblocking events when blockade
kinetics are fast, resulting in the decrease of apparent mean current amplitude. For a
charged blocker that binds within the open pore of a channel, blockade kinetics are
- 72 -
sensitive to the transmembrane voltage, meaning that the decrease in single-channel
currents is a function of membrane potential. The Woodhull model can be described as:
binding k+B site kB + B - site -.. B
site k-B
(extracellular) (pore) (intracellular) (6)
where k+B is the blocker association rate constant (from the extracellular side), k-B is the
blocker dissociation rate constant (to the extracellular side), and kp is the blocker
permeation rate constant (to the intracellular side). The binding of blocker from the
intracellular side is assumed to be negligible. At a given membrane potential (V), the
mean amplitude of single-channel currents in the presence of a blocker is:
i'(V) = i(V) 1 + G(V)+ [B]G(V) (7)
where [B]ex is the blocker concentration in bulk solution, i(V) is the single-channel
current amplitude in the absence of blocker, G(V) and H(V) are k,/k_B and k+B/k-B,
respectively, as defined below (z = the charge of blocker):
k ( - zFV
G(V) - - Go exp-2 ) (8)
k-B 2RT
H(V) - k +B -H ex p  (9)kB RT
The parameter 8 in Equation 9 is the electric distance, the fraction of the
transmembrane voltage drop experienced by the charged blocker when entering the
binding site. Assuming that the transmembrane electric field drops linearly with the
depth in the membrane, 6 can serve as a measure of the binding site location. For the
analysis of la, i '(V) was obtained directly from SKM idealization and i(V) was identified
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from the peak of the "unblocked" state in the amplitude histogram (Figure 2.4C).
Fractional blockade is defined as i'(V)/ i(V). Fitting the (i'/i)-V curve with z = 2, F =
96485 Cmol-', R = 8.314 JK 'mol-', and T= 298.15 K provides 8, Go (i.e., kp/kB at 0 V),
and Ho (i.e., klB/k-B at 0 V) at 25 "C (for a discussion on z, see section 2.4.1). A
representative plot of(i'/i) vs. membrane potential (V) with fitting is shown in Figure 2.5.
By Woodhull analysis, 8 is estimated as 0.32 ± 0.05 (mean + S.D.) at 25 "C. Assuming
that the transmembrane voltage drops linearly within a 40 A-thick membrane, la is
estimated to bind -13 A deep from the extracellular side of the cell membrane.
The observations from concentration- and voltage-dependent measurements
support a mechanism in which la and lb bind transiently within the transmembrane
lumen and impede ion conductance through the open AChR. Because the effects of la
and lb on open-AChR currents were not observed with the free PEG, the bivalent and
monovalent PEG-TMA conjugates demonstrate that attaching at least one positively
charged moiety to the PEG backbone enhances the molecule's affinity for the channel
pore.
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Figure 2.5. Estimation of electric distance (6) for compound la using the Woodhull model. A
representative file at 100 tM la is shown. The plot of (i'/i) vs. membrane potential was fitted
according to Equation (7), giving 8 = 0.32 ± 0.05, Go = 0.0096 ± 0.0011, and Ho = 530 ± 170 M'
at 25 "C (the values are reported as mean + S.D. from triplicates).
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2.3.2. The Effects of PEG Length on Blockade Kinetics
The Effect of PEG Length on the Apparent Mean Open Time (ro). PEG-TMA
conjugates la and Ib, which were derived from tetra(ethyleneglycol), exhibit
open-channel blockade of the AChR with high-jtM Kds. In our blocker design strategy,
we hypothesize that if a polymer-based blocker is confined within the transmembrane
lumen, the interactions between each monomer unit and the pore interior would be
additive. Therefore, increasing the number of monomer units in the polymer backbone
is expected to increase the overall blocker-channel interactions, leading to a tighter
binding. To test whether blockade affinity can be enhanced by extending the backbone
size, a series of bivalent PEG-TMA conjugates (2-6, Figure 2.6) synthesized from
various sizes of PEG were tested by single-channel electrophysiology. The average size
of each PEG-TMA conjugate is estimated as the Flory radius (RF) of its precursor PEG
[9].
I
number of
compound M.W. of PEG monomer units R (A)
monomer units (N)
la 194 4 8.0
2 370 8 12.2
3 -590 -13 16.3
4 ~1000 -22 22.4
5 -3400 -77 47.4
6 -10000 -227 90.7
Figure 2.6. Structure and estimated size of the bivalent TMA-PEG conjugates. The size of
each precursor PEG is estimated as the Flory radius (RF = aN0 6, a = 3.5 A for PEG) [9].
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The effects of each PEG-TMA conjugate on AChR currents were first examined
on the channel's To. Like la and ib, compounds 2-6 are all capable of stimulating
AChR currents at 100 pM, but the currents show different features (Figure 2.7).
Compounds 2 and 3 do not cause well-defined bursts of opening events, but the To values
at 100 pM 2/3 are relatively short (0.21 ± 0.01 and 0.42 ± 0.04 ms, respectively; Figure
2.7) compared to the To under the control condition (100 pM tetra(ethylene glycol) + 200
pM TMA; To = 0.76 ± 0.32 ms). Compounds 4-6 induce step-like, steady AChR
currents and the 0o values are close to that under the control condition (Figure 2.7). The
brevity in To observed with compounds 2 and 3 suggest that these compounds also cause
open-channel blockade and that they dissociate from the pore more slowly than la and lb
do. To test this hypothesis, we characterized concentration and voltage dependences of
these compounds' effects on AChR currents.
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Figure 2.7. Single-channel electrophysiological characterizations of the bivalent PEG-TMA
conjugates. (A) Representative traces at 100 pM of each bivalent PEG-TMA conjugate alone
(holding potential = +70 mV). Currents are presented as upward deflections. (B) The apparent
mean open time (To) of the AChR at 100 AM of each tested compound. Error bars represent
standard deviations of triplicates. The control condition contains 100 ipM tetra(ethylene glycol)
and 200 pM tetramethylammonium (TMA) chloride.
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Figure 2.8. Representative histograms of closed- and open-time distributions at low and high
concentrations of compound 2. Arrows indicate the closed-time components corresponding to
the "blocked" state.
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Figure 2.9. Representative histograms of closed- and open-time distributions at low and high
concentrations of compound 3. Arrows indicate the closed-time components corresponding to
the "blocked" state.
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Concentration Dependence of Blockade by Compounds 2 and 3. The observed
decrease in to values suggest that compounds 2 and 3 may act as blockers of the open
AChR. Classical open-channel blockade (Equation 3 in section 2.2.4) conforms to the
following predictions: (1) to decreases with increasing concentration of the blocker ([B]);
(2) mean duration of the blocked state (TB) is independent of [B] and the unblocking rate
constant (k-B) is the reciprocal of TB; and (3) blockade kinetics are voltage-dependent
(due to blocker binding within the transmembrane electric field) [23]. To evaluate these
predictions for AChR blockade by compounds 2 and 3, we first examined -o at various
concentrations of each compound. The open-time histograms, which can each be fitted
by a single-exponential distribution under all conditions, show that the opening durations
at higher concentrations of 2 or 3 are significantly shorter than those at lower
concentrations (Figure 2.8 and 2.9).
In the sequential blockade model, the concentration dependence of To can be
described as:
1
- a + k+B[B] (10)
where a is the closing rate constant of the channel and k+B is the blocking rate constant.
As shown in Figure 2.10, a linear relationship between 1/To and [B] is observed for both 2
and 3. The values of k+B and a are given by the slope and y-intercept, respectively, of
the linear fits. The k+B values for compounds 2 and 3 are 36 + 1 and 10 ± 1 pM-'s',
respectively.
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Figure 2.10. (A) Increase of 1/to as a function of blocker concentration. Data were fitted by
least-squares linear regression. (B) The dissociation rate constant (k-B) of compounds 2 and 3 at
various concentrations. The values of k_B were obtained from the results of fitting the
closed-time histograms by MIL.
In addition to -ou, the closed-time distribution also changes in a
concentration-dependent manner (Figures 2.8 and 2.9). For instance, the closed-time
distribution in the presence of compound 2 is composed of two exponential components.
The faster component has a relatively constant lifetime of 2-4 ms within the tested
concentration range, whereas the lifetime of the slower component varies with the
channel activity. In addition, the fast component represents a greater fraction of the
total closing events as the concentration of compound 2 increases. Both observations
suggest that the fast component represents the blocked state of the AChR. In the context
of the sequential blockade mechanism (Equation 3 in section 2.2.4), the unblocking rate
constant (ks) is the reciprocal of the mean blocked time (TB). Because k is fairly
constant over the tested concentration range (Figure 2.10), a mean value is calculated for
compound 2 (339 ± 78 s-'). Similar blockade behavior is also observed with compound
3 (Figures 2.9 and 2.10), and the mean value of k8 for compound 3 is 82 + 34 s-1.
- 80 -
Voltage Dependence of Blockade by Bompounds 2 and 3. The concentration
dependences of to and kB are both consistent with the predictions for open-channel
blockade. We therefore went on to examine the voltage dependence of blockade
kinetics. Although to does not show a significant voltage dependence for compound 2
or 3 (Figure 2.11B), a, k+B[B], and k-B clearly exhibit changes with the membrane
potential for both blockers (Figures 2.11C and 2.11D). Compounds 2 and 3 share
similar trends in these rates. The increase of intrinsic to (i.e., the mean open time of the
channel in the absence of blockade) with hyperpolarizing (i.e., more negative) membrane
potential has previously been reported for the AChR [15]. Because the intrinsic to is
defined as i/a, a is expected to decrease with membrane hyperpolarization, which is
consistent with the trends observed with both 2 and 3. The blocking rate, which is
defined as k+B[B] in the sequential blockade model, increases with hyperpolarizing
membrane potential. Since [B] is constant during the measurements (100 pM for
compound 2 and 200 pM for compound 3), the observed trend is in fact the
voltage-dependence of k+B for these blockers. For positively charged molecules,
increasing k+B with hyperpolarizing membrane potential is indicative of open-channel
blockade from the extracellular side of the channel. Moreover, since blocker association
generally reduces to, the lack of voltage-dependence in to is presumably due to offsetting
effects of k+B and a.
There is only a marginal variation in kB with voltage when the membrane
potential is less negative than -120 mV. At more hyperpolarizing membrane potentials,
a more significant increase in k_B can be observed (Figures 2.11C and 2.11D). A faster
blocker dissociation rate leads to a shorter mean duration of the "blocked" state of the
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channel, which can be identified from the shift of the fast component in the closed-time
distribution (Figure 2.12). At more negative membrane potentials, the closed and
blocked states of the AChR are more kinetically distinguishable, which allows direct
visualization of "burst-like" opening events (Figure 2.11A). The cause of increasing k-B
with membrane hyperpolarization is not yet clear: it might be permeation of the blocker
into the cell [24, 25] or faster release of the blocker into the extracellular solution (due to
the destabilization of blocker-channel interaction).
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Figure 2.11. Voltage-dependent blockade by compounds 2 and 3. (A) Representative traces.
Currents are presented as upward deflections. (B) The change of apparent mean open time (to)
with membrane potential. (C and D) Voltage dependence of blockade kinetics at 100 /IM
compound 2 (C) and 200 tM compound 3 (D). Filled squares, channel closing rate (a); filled
circles, blocker association rate (k+B[B]); empty circles, blocker dissociation rate (k-B). One
representative file for each condition is presented. The values of k+B[B] and kB were obtained
from the results of fitting the open- and closed-time histograms by MIL.
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Figure 2.12. Representative histograms of closed-time distributions at different membrane
potentials. Arrows indicate the closed-time components corresponding to the "blocked" state.
(A) At 100 pM compound 2. (B) At 200 pM compound 3.
The electric distance (8) for compounds 2 and 3 can be estimated from the voltage
dependence of k+B. For a charged blocker binding within the transmembrane electric
field, the activation free energy for blocker association is voltage dependent. The
blocking rate constant (k+B) can be described as a function of activation energy according
to Eyring rate theory [22, 27-29]:
(- z F
k+ = b exp (11)
where b is a voltage-independent component of k+B, z is the charge of the blocker, F is
Faraday's constant, R is the gas constant, and T is the absolute temperature. According
to Equation 11, the plot of ln(k+B) vs. membrane potential (V) is expected to be linear,
and the slope (-zbF/2RT) describes the contribution of electrostatic interactions between
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the blocker and the transmembrane electric field to the activation free energy. For
compounds 2 and 3, k+B increases with hyperpolarizing membrane potential; 5 for these
molecules is thus estimated from the slope of the ln(k+B) vs. V plot, as shown in Figure
2.13. Using z = 2, F= 96485 Cmol', R = 8.314 JK'mol', and T= 298.15 K, 8 (mean
± S.D.) was estimated as 0.25 + 0.06 and 0.19 + 0.07 for compound 2 and compound 3,
respectively (for a discussion of z, see section 2.4.1).
18.5- 1lO pMcpd2
0 200pMcpd 3
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S17.0
16.5-
16.0
-0.20 -0.15 -0.10 -0.05
membrane potential (V)
Figure 2.13. Estimation of electric distance (5) for compounds 2 and 3 using the Eyring rate
equation. A representative file for compound 2 (filled square) and compound 3 (filled circle) is
shown. Least-squares linear regression of the ln(k+B) vs. V plot provides slope = -z6F/2RT.
The Effects of PEG Size on AChR Blockade. The rate constants (a, k+B, and k-B)
and equilibrium dissociation constant (Kd) determined above are summarized in Table 2.1.
In the series comprising compound la through compound 3, each extension of the PEG
backbone leads to a -4 A increase in the length (estimated from the Flory radius of the
precursor PEG). The channel closing rate constant (a) of the AChR appears to be
unaffected by the size of these bivalent compounds. Although we did not perform a
direct measurement of a for la and lb, an approximate measurement of a from
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recordings at low concentrations (5 pM for la and 10 pM for ib, where fractional
blockade is less than 10%) gives values around 1300 s-1 for these compounds, which are
close to the values observed for compounds 2 and 3. Both k+B and kLB are inversely
correlated with PEG size (Table 1 and Figure 2.14). Using la as a reference compound,
the addition of four and nine ethylene glycol units causes 4.7- and 16-fold decreases in
k+B, respectively. The trend in kLB is more dramatic: the addition of four and nine
ethylene glycol units leads to 100- and 430-fold decreases in kB, respectively. The
differential PEG length sensitivity of k+B and kB results in a significant enhancement of
binding affinity for both 2 and 3 compared to la. It is worth noting that, although
compounds 2 and 3 exhibit distinct blockade kinetics, their binding affinities are similar
(Table 2.1).
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Table 2.1. Rate and Equilibrium Dissociation Constants for the
PEG-Based Blockers.
compound a k+B k-B Kd
(PEG size)a (S-1)b (tMs-1-)c (S-) ( M)e
la(8.0 A) -- 168 + 17 (3.53 + 0.23) x 104  210 ± 25
2(12.2 1340 ± 19 36 ± 1 339 ± 78 9 ± 2(12.2 A)
3(16.3) 1300+ 116 10 1 82 34 8 3(16.3 A)
lb
(8.0 A) -- 37 ± 15 (3.01 + 0.40) x 104  848 ± 358
a The size of PEG was estimated as the Flory radius (RF= aN° 6, a = 3.5 A for PEG) [9].
b Channel closing rate constants (a) were estimated from the y-intercept of linear plots of 1/to vs. [B]
(Figure 2.10A).
Blocker association rate constants (k+B) of la and lb were obtained from noise analysis (Figure 2.3D).
Values of k+B for 2 and 3 were estimated from the slope of linear plots of 1/t vs. [B] (Figure 2.10A).
d Blocker dissociation rate constants (k-B) of la and lb were obtained from noise analysis (Figure 2.3D).
For 2 and 3, values of k-B estimated from MIL fitting at various blocker concentrations were pooled for
calculation (Figure 2.10OB). The mean ± standard deviation values from 20 and 12 patches are reported
for 2 and 3, respectively.
The equilibrium dissociation constant (Kd) for the blocker is defined as k-BlkB.
2 4 6 8 10 12 1'4
number of (ethylene glycol) unit
2 4 6 8 10 12 14
number of (ethylene glycol) unit
Figure 2.14. Dependence of ln(k+B) (A) and ln(kB) (B) on spacer size (expressed as the number
of ethylene glycol units). The solid lines are least-squares linear fits.
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2.4. Discussion
In the present study, the proposed blocker design strategy was investigated with a
series of PEG-TMA conjugates. We found that the installation of at least one QA group
on the PEG backbone is required for blockade. For symmetric, bivalent blockers
(la-3), varying the length of the PEG spacer between the two QA groups leads to
systematic changes in the blocking and unblocking rate constants. Implications for
future design of polymer-based, kinetically tunable blockers will be discussed.
2.4.1. The Mechanism of Blockade
The results of electrophysiological studies suggest that compounds la, ib, 2, and
3 all function as open-channel blockers of the AChR (Figure 2.15, pathway A). For
compounds 2 and 3, the dose-dependent reduction in to and the presence of a faster
kinetic component (which has a fairly constant lifetime over the tested concentration
range) in the closed-time distribution are in good agreement with the sequential blockade
mechanism (Equation 3 in section 2.2.4). Compounds la and lb do not reduce to but
instead cause burst-like flickering events and increased current noise. The
dose-dependent increase in Tburst observed with la and lb suggest fast blocking and
unblocking of the open channel by these compounds. The voltage dependence of AChR
blockade by compounds la, ib, 2, and 3 further supports a mechanism in which these
molecules block the open pore of the channel (Figure 2.15, pathway A). In general,
blockade is sensitive to changes in the membrane potential when a charged blocker binds
within the transmembrane electric field. The voltage dependence of blockade can be
used to obtain a rough estimate of the location in which blocker binds within the
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transmembrane lumen. For fast blockade by la, the electric distance 6 (i.e., the fraction
of total transmembrane potential drop measured from the extracellular side of the
membrane to the blocker binding site) can be estimated using the Woodhull model,
yielding a value of 0.32 ± 0.05 (Figure 2.5) [18, 22, 26]. Because a clear
voltage-dependent increase in k+B with hyperpolarization is observed for compounds 2
and 3, the 6 values for these blockers can be estimated according to the Eyring rate
equation [22, 27-29]. By linear fitting of the plot of ln(k+B) vs. membrane potential, 8
can be calculated as 0.25 ± 0.06 and 0.19 ± 0.07 for compounds 2 and 3, respectively,
from the slope (Figure 2.13). Assuming a membrane thickness of 40 A, the binding
sites of la, 2, and 3 are 13 ± 2, 10 + 2, and 7 + 3 A from the extracellular side of the
membrane, respectively.
It should be noted that 8 only provides a rough estimate for the blocker binding
site within the membrane, and caution should be taken while interpreting the results.
The values of 8 for la, 2, and 3 were estimated by assuming that the blockers are
condensed particles with a charge of +2. However, the two QA groups are separated by
a PEG spacer about 1 nanometer long. The two QA groups should experience different
degrees of changes in the transmembrane voltage unless the molecules form hairpin-like
conformations to place the two QA groups together. Therefore, the effective charge
used to calculate 8 is more likely to be 1<z<2 for a bivalent PEG-TMA conjugate. la, 2,
and 3 are likely to reach sites deeper than those predicted by z = +2.
Compounds la-3 are weak agonists of the AChR in addition to being channel
blockers. The agonist potencies of la-3 indicate that these compounds also bind the
agonist sites of the AChR. Moreover, la-3 have two quaternary ammonium groups
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attached at the termini of PEG, suggesting that these molecules are also likely to bind an
agonist site with one end and block the channel by the rest of the molecule. For
instance, the bivalent PEG-TMAs might span the agonist site and the transmembrane
pore or the extracellular vestibule (Figure 2.15, pathway B). Alternatively, the bivalent
compounds might span the two agonist sites across the extracellular vestibule (Figure
2.15, pathway C). In these mechanisms, occupation of the PEG backbone in the
vestibule tunnel is likely to interfere with ion conduction. However, several lines of
evidence suggest that these blockade mechanisms are not feasible. The agonist sites are
-40 A above the cell membrane [30], suggesting that compounds la-3, which are 8-16
A long, are unlikely to span the pore and the agonist site (Figure 2.15, pathway B). The
observed voltage-dependent blockade with these compounds also excludes a mechanism
in which a bivalent PEG-TMA spans the agonist site and the interior of the vestibule
tunnel. In such a mechanism (Figure 2.15, pathway B), the positively-charged blocker
would act at a position distant from the transmembrane region and blockade would
therefore be insensitive to transmembrane voltage changes, which is in contrast to our
observations. In addition, the structure of the Torpedo AChR (PDB entry: 2BG9) [30]
shows that there is only limited access to the vestibule chamber from each agonist site
and that the agonist binding pockets are open to the exterior. Therefore, once a bivalent
PEG-TMA binds the agonist site, the unbound trimethylammonium group is more likely
to reach the external medium than the interior of the vestibule chamber. Finally,
concentration-dependent blockade by la-3 would not support blockade mechanisms that
rely on binding of the PEG-TMA to the agonist site (Figure 2.15, pathways B and C):
such mechanisms are intramolecular processes in which channels are blocked
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independently of blocker concentration. Similar arguments can also be used to exclude
the mechanism in which a bivalent PEG-TMA spans the two agonist sites across the
extracellular vestibule (Figure 2.15, pathway C).
insufficient PEG length
limited access to the vestibule tunnel
ni
n =2 (la, RF= 8 A)
n = 6 (2, RF = 12 A)
(voltage insensitive) n - 11 (3, R ~- 16 A)
-20 A
agonist site
(voltage sensitive)
(voltage insensitive) (voltage sensitive)
insufficient PEG length
limited access to the vestibule tunnel
Figure 2.15. Possible blockade mechanisms by bivalent PEG-TMAs (la-3). (A)
Open-channel blockade. (B) Intramolecular blockade by bivalent binding to an agonist site and
the transmembrane pore/extracellular vestibule tunnel. (C) Intramolecular blockade by bivalent
binding to the two agonist sites within the same channel. Detailed discussions about these
mechanisms can be found in Chapter 2.4 (p. 87-90). Note that the figures are not drawn to
scale. RF: Flory radius as determined by aN0.6 (a = 3.5 A for PEG) [9].
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2.4.2. The Effect of the Attached Charged Moiety on Blockade
Observation of blockade with lb but not the free PEG suggests that having one
QA moiety is sufficient for a PEG reagent to bind the AChR pore. However,
incorporation of a second QA group (la) further improves blocker affinity. Comparing
Kd, k+B, and kB of la and lb, we find that la binds the AChR pore with 4-fold higher
affinity than ib, and that the difference in binding affinity predominately comes from the
blocking rate constant (kB). Although an increase in the effective concentration of the
charged moiety can contribute to this difference, the bivalency of la produces only a
2-fold increase in [QA] over lb, which could account for a difference in k+B of at most a
factor of two. An alternative explanation is that the additional QA group of la increases
the probability of productive binding with the AChR. Prior to pore blockade, the
blockers may form short-lived pre-association complexes with the negatively charged
extracellular vestibule. The higher charge density of la might stabilize its residence in
the vestibule, making productive collisions of la with the pore more likely.
Neither tetra(ethylene glycol) (100 pM) nor tetramethylammonium (200 p~M)
caused observable blockade in our measurements, suggesting that their Kds for the AChR
pore are in the millimolar range or greater. This observation is consistent with the
descriptions in earlier single-channel studies with PEG and small QAs. PEGs were
previously found to have very weak affinities to the pore of at-hemolysin (Kds of high
millimolar or higher) [7], and small QAs such as TEA were reported to block the AChR
with a Kd of 2.4 mM [21]. In our study, however, AChR blockade can be observed at
micromolar concentrations when the two moieties are covalently linked. The Kds of the
PEG-based blockers identified here range from -850 pM to -10 p.M, indicating that both
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the backbone and the charged moieties contribute to the blocker's binding affinity for the
pore. Covalent conjugation of the blocker components appears to enhance each
moiety's affinity to the AChR pore. The results support two of our hypotheses for
polymer-based blocker design: (1) the electrostatic interaction between the positively
charged moiety and the transmembrane electric field (and presumably the channel pore)
makes channel blockade by a PEG reagent possible; and (2) the PEG backbone can
partition into the transmembrane pore and interact with the pore interior. The length
dependences of blockade kinetics are discussed in the following section.
2.4.3. The Effects of PEG Length on Blockade Kinetics
Both k+B and kB were found to decrease systematically with PEG size (Figure
2.14). The length-dependent decrease in k+B is suggestive of an entropic barrier that
prevents partitioning of bulky PEGs into the channel pore. Sulfhydryl-directed PEG
reagents have been previously reported to partition into the pore of a-hemolysin
according to a simple scaling law [9]. A linear relationship was found between the
natural logarithm of the apparent rate constant (k) for a specific luminal cysteine residue
and the number of ethylene glycol units (N) in the PEG reagent. The slope of this linear
correlation was -(a/D) 5/3, where a is the persistence length (i.e., effective monomer
length) of the polymer and D is the pore diameter. Analogously, the plot of ln(k+e) vs.
N is linear for our PEG-based blockers (Figure 2.14A). Since blockers la-3 are smaller
than the diameter of the vestibule tunnel (20-30 A) [30] but larger than the pore diameter
(7-8 A) [31, 32], the entry of these molecules into the transmembrane pore is expected to
contribute predominately to the entropic cost of blockade. Assuming a persistence
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length of 3.5 A for PEG [9], a diameter of 7.1 A is obtained according to the slope of the
linear fit (slope = -(a/D)5/3), which is in good agreement with the reported value for the
pore diameter of the AChR [31, 32]. The length dependence of k+B for compounds la-3
therefore supports the hypothesis that the primary entropic barrier for blocker association
is the partitioning of a polymeric scaffold into the transmembrane pore.
The dissociation rate constant is found to be inversely correlated with the length
of PEG. Assuming that the interaction between the channel and each monomer unit is
identical and additive, the activation energy for blocker dissociation can be estimated
from:
k_ = A exp (o A exp -Nx Eaun) (12)
RT RT
where A is the proportionality constant, N is the number of ethylene glycol units, and Ea
(total) and Ea (unit) are the overall activation energy for blocker dissociation and activation
energy for dissociation per monomer unit, respectively. According to Equation 12, the
plot of In(k_B) vs. N is linear with a slope of -(Ea (unio/R T). Linear least-squares fitting
suggests that each ethylene glycol unit contributes -0.4 kcal/mol of binding energy in the
series la-3 (Figure 2.14B), although the correlation between the number of monomer
units and the total binding energy may not be strictly linear (see discussion below).
By extrapolating the linear correlation between ln(k+B) and N (Figure 2.14A), k+B
of compound 4 (N- 22) is estimated to be 0.6 riM-ls-'. Using this estimate, the blocking
rate is predicted to be only 0.06 ms-' at 100 ipM of compound 4. Since the intrinsic to
for our PEG-TMA conjugates are 0.7-0.8 ms, the probability of observing blockade
events before the open AChR closes is expected to be very low under this condition.
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Moreover, because the size of compound 4 (RF = 22.4 A) is close to the diameter of the
extracellular vestibule, the entropic cost for compound 4 to enter the vestibule should not
be neglected. The concentration of PEG-1000 in a 20-A chamber is -30% of that in the
bulk solution according to scaling law [9], giving an even lower k+B for compound 4 than
predicted from the scaling analysis in Figure 2.14A.
The value of k-s is also likely to deviate from the predicted value (Figure 2.14B
and Equation 12) when N is large. For small PEG-based blockers, the interaction
between the channel and each monomer unit is assumed to be identical and additive
because these molecules may be fully confined in the transmembrane lumen, forming
favorable interactions with the pore interior. For large congeners, however, the polymer
size might exceed the space available for blocker binding within the pore, leading to
weaker binding (and hence faster blocker dissociation). Such a deviation might explain
our observed length-dependent trend in kB: the drop in In(kB) is steeper from N = 4 to N
= 8 compared to the decrease from N = 4 to N = 13 (Figure 2.14B, dashed lines).
The blockade behaviors of la-3 are similar to those of the previously reported
PIP derivatives [22] in that there is a linear decrease in ln(k_B) with increasing number of
methylene groups in the alkyl tail. As proposed for the PIP derivatives, this effect is
presumably due to differential hydrophobic interactions between each blocker and the
nonpolar pore-lining residues of the AChR. Interestingly, however, kBa for the PIP
derivatives remains fairly constant without a particular trend over the range of alkyl chain
length examined, which is in contrast to our observation with PEG-TMA conjugates.
Because changes in molecular size are much smaller for the PIP derivatives (R = methyl
to hexyl) than those for compounds la-3, the entropic barrier for the entry of a PIP
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derivative is expected to depend only weakly on the alkyl chain length over the range
tested.
2.4.4. Implications for the Design of Kinetically Tunable Blockers
Work described in this chapter demonstrates our blocker design strategy which
uses a flexible polymeric material, PEG, as the blocker scaffold. Two structural
determinants have been identified for PEG-based blockers of the AChR: (1) at least one
positively charged moiety (e.g., trimethylammonium) is required; and (2) the backbone
size is around 4-13 ethylene oxide units for a micromolar pore affinity. The blocking
and unblocking rate constants each exhibits a characteristic dependence on PEG length,
suggesting that it is likely to create blockers with predictable blockade kinetics by
adjusting the size of the polymer backbone. In terms of their binding kinetics and
thermodynamics, blockers la-3 are comparable to the QA-based blockers that have
previously been characterized (Table 2.2). Blockers 2 and 3 exhibit AChR binding
affinities comparable to those of the well-known QA-based open-channel blockers such
as decamethonium (Kd = 9-20 p.M) [19] and QX-222 (Kd - 30 pM) [23]. It is also
worth noting that k+B and k-B of blockers la-3 span one and two orders of magnitude,
respectively, and that these ranges cover the blockade rate constants of many previously
characterized QA-based blockers (Table 2.2).
Due to the lack of a high-resolution structure for the transmembrane lumen, the
rational design of open-channel blockers for the AChR remains challenging. The
observed length-dependent changes of blockade kinetics in this study suggest an
alternative strategy for blocker design: when a flexible polymer scaffold is incorporated
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into the blocker structure, a systematic modulation of blocker association/dissociation
may be achieved by modifying the size of the polymer scaffold. This study has
demonstrated that simple PEG-TMA conjugates can block the open AChR with
reasonably good affinities and length-dependent blockade kinetics. Further studies on
the effects of the QA structure on the behavior of a PEG-based blocker are described in
Chapter Three.
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Table 2.2. Blockade of the AChR by QA-Based Open-Channel Blockers.
compound structure kB- k-B (S1)  Kd Ref.
la 16817 (3.53 0.23) 10 25M -- 17 104  2 + 5 IM
2 "' 36 ± 1 339 ±78 9 ± 2 gM
3 )-oIN 10 ± 1 82 ± 34 8 3 M --
0
acetylcholine o 37 56000 1.2 mM 17
choline HO -- -- 12.5 mM 33
tetraethylammonium
(TEA) -- -- 2.7mM 21
decamethonium IN 29 265 - 571 9 - 20 tM 19
phenylpropyl-
trimethylammonium N 26 2347- 4255 90 - 160 giM 19
(PPTMA)
SQX-222 21 - 600 - 30 jM 23
0 94 2179 23 M 34
QX-314 19 -30 - 1 ,M 23
PIP (N 42 144000 3.4 mM 22
hexylPIP 22 980 45 pM 22
IEM-1460 N - 72 858 12 ,M 35
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Chapter Three
The Effects of End-Group Structure on the Function
of a Poly(ethylene glycol)-Based Blocker for
the Acetylcholine Receptor
In Chapter Two, we demonstrated that short poly(ethylene glycol)-
trimethylammonium (PEG-TMA) conjugates are potent open-channel blockers for the
muscle-type nicotinic acetylcholine receptor (AChR) and that blockade kinetics can be
quantitatively modulated by PEG length. Here we study the effects of end-group
structure on blockade kinetics/affinity and agonist potency of a PEG-based blocker. The
tested compounds (7a-7e) share the same PEG size but differ in the quaternary
ammonium (QA) groups attached. Our results show that the QA group plays an
important role in both the activation and the blockade of the AChR by a PEG-QA
conjugate. Blockade affinity is greatly enhanced when the TMA group is replaced by
bulkier QAs, mainly due to the decrease in unblocking rate constant. We also find that
the tested molecules exhibit two modes of blockade and that the structure of the QA
influences the rates of entering the two modes. The blockade mechanism and future
applications of PEG-QA conjugates are discussed.
3.1. Introduction
In Chapter Two, the proposed structure-independent strategy for designing open-
channel blockers has been demonstrated with short PEG-QA conjugates (compounds la,
ib, 2, and 3). These molecules exhibit length-dependent blockade kinetics that can be
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described quantitatively: the blocking rate constant (k+B) and the unblocking rate constant
(k-B) are determined by the partitioning of PEG into the channel pore and the additive
non-polar interactions between the PEG backbone and the transmembrane lumen,
respectively. These blockers are also capable of inducing opening of the AChR,
indicating that the agonist sites of the AChR can accommodate the bulk of the PEGs.
The QA groups are expected to interact with the transmembrane electric field and direct
the blockers to target the pore. To allow the blocker affinity to be attributed
predominately to PEG-channel interactions, trimethylammonium groups are used to
minimize the interactions between the substituents of the QA groups and the pore
interior.
The structure of the QA group may play an important role in defining the
blockade kinetics and/or pore-binding affinity of an open-channel blocker. Bakry et al.
reported that increasing the chain length of a symmetrically substituted
tetraalkylammonium salt (from tetramethyl to tetrahexyl) increased its affinity for the
pore of the Torpedo AChR [1]. The open-channel affinity (estimated by single-channel
analysis) of a lidocaine derivative, QX-222 (Figure 3.1), was found to increase -30 fold
when the trimethylammonium group was replaced by triethylammonium [2]. A similar
result was also found from another isotope ligand binding assay, in which replacing the
trimethylammonium of QX-222 with larger QAs (such as diethylmethylammonium or
triethylammonium) led to a decrease in the blocker's IC5o [3]. In a structure-function
study of p-phenylene-polymethylene bis-ammonium (PMBA, Figure 3.1) compounds by
patch-clamp electrophysiology, Nojima et al. also reported that bis(triethylammonium)
derivatives exhibited higher AChR blocking potencies than did bis(trimethylammonium)
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derivatives [4]. These studies indicate that the substituents of the QA group may interact
with the hydrophobic environment of the AChR pore, providing another source of
binding affinity in addition to the core scaffold attached to the QA.
N R3N (CH2)(CH 2)nNR 3
SH 
PMBA IEM-1754
(n = 2 to 4)
Figure 3.1. Open-channel blockers previously reported in structure-function studies of AChR
inhibition.
When the scaffold of an open-channel blocker is bulky with respect to the QA
substituents, however, the effect of QA structure on blockade may be insignificant.
Antonov et al. reported that replacing the ammonium group of IEM-1754 (Figure 3.1)
with other QAs such as trimethylammonium, isopropyldimethylammonium, and tert-
butyldimethylammonium only led to a marginal change in blockade kinetics and affinity
[5]. It was suggested that the scaffold, 5-(1-adamantanemethylammonio)pentane, plays
the principal role in pore binding. In addition, the binding site of IEM-1754 is shallower
than that of QX-222 [2, 6], indicating that the contribution of the QA group to blockade
affinity may also be determined by the local environment surrounding the bound blocker.
Many QA compounds act as both agonists and open-channel blockers of the
AChR [4, 7-11]. The structure of the QA moiety may modulate a blocker's potency of
stimulating channel opening. For instance, PMBA blockers were found to stimulate
AChR openings in the absence of other agonists, and the agonist potencies of
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bis(trimethylammonium) derivatives was higher than those of bis(triethylammonium)
derivatives [4]. The space for recognizing a QA group in the AChR's agonist sites may
be limited. The agonist-site affinity of symmetric tetraalkylammonium salts for Torpedo
AChR was estimated by Bakry et al. via measuring the inhibition of tritium-labeled
acetylcholine ([3H]ACh) binding to Torpedo membranes [1]. The results showed that
increasing the size of alkyl substituents decreased the QA's affinity for the agonist sites
while increasing its affinity for the AChR pore, suggesting that the agonist sites are less
tolerant to bulky QA substituents compared to the channel pore. Modification of the QA
structure therefore provides a promising way of tuning a blocker's agonist potency
without sacrificing its pore affinity.
The goal of this chapter is to investigate the effects of QA structure on the
blockade kinetics, pore affinity, and agonist potency of the symmetric PEG-based
blockers. The prototype molecules (Figure 2.6) studied in Chapter Two are composed of
a PEG backbone (of varying sizes) with a trimethylammonium group at each end. Here
we aim to understand whether the substituents of the QA groups play an important role in
binding to the AChR pore and whether the agonist potency of the prototype blocker can
be reduced by changing the QA groups. Five symmetric PEG-QA conjugates (7a-7e,
Figure 3.2) were tested in this study. These compounds were derived from octa(ethylene
glycol) (i.e., PEG-370) by converting the hydroxyl groups of the precursor PEG into N-
methylpyrrolidinium (7a), N-methylpiperidinium (7b), N-ethylpiperidinium (7c),
triethylammonium (7d), and N-methyldipropylammonium (7e).
Octa(ethylene glycol) was chosen as the backbone moiety for two reasons. First,
based on the unblocking rate constant of the prototype blocker (compound 2 in Figure
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3.2, k-B = 339 s-'), blockers of this size are expected to cause blockade events resolvable
at our recording bandwidth. Well-resolved events would facilitate an extensive kinetic
analysis at the single-channel level. Second, the prototype blocker (2) derived from
octa(ethylene glycol) has a high blocking rate constant (36 M-l's-1). The homologues are
therefore expected to cause appreciable blockade events within the range of the tested
blocker concentrations. The QA groups chosen are small relative to the backbone length,
and the overall size of each compound is therefore expected to be similar.
2, QA= - -N- 7c, QA - -
(prototype)
QA O O 7a, QA= -lN 7d, QA= -- N
6
7b, QA = -- N 7e, QA = - N
Figure 3.2. Structures of the symmetric PEG-QA conjugates studied in this chapter and their
prototype molecule (i.e., compound 2 in Chapter Two).
All of the tested compounds are found to abbreviate the mean duration of AChR
openings stimulated by 100 jM ACh in a dose- and voltage-dependent manner,
suggesting that these molecules exhibit open-channel blockade. For 7a-7d, two modes
of blockade are found to cause the observed decrease in the apparent mean open time.
The two modes differ in the unblocking rate constant: the faster-dissociation mode has a
k_B of 45-85 s-1 and the slower-dissociation mode has a k-B around 2-4 s-1. The rate
constants of entering these modes vary with the structure of the QA groups in 7a-7d.
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Only the slower-dissociation mode is found for 7e. For all of the tested molecules, the
slower-dissociation mode leads to a sub-micromolar blockade affinity, which is
comparable with the pore-binding affinities of the previously reported long-lived blockers
(+)-tubocurarine and quinine [12-14]. The agonist potencies of PEG-QAs also vary with
the end-group structure. At 10 tM, 7d stimulates appreciable channel activity (open
probability - 10-2), whereas 7c and 7e induce brief spikes of opening at a very low
frequency (life time < 0.2 ms; open probability < 10 ). Taken together, the results show
that the end-group structure plays an important role in determining the blockade kinetics,
blockade affinity, and the agonist potency of a PEG-QA conjugate. Combining the
results in the present chapter and Chapter Two, this thesis work demonstrates that PEG is
a highly versatile scaffold for creating open-channel blockers that span a broad range of
blockade kinetics and affinity. PEG is therefore a promising building block for open-
channel blockers or pore-directed probes of the AChR, and perhaps other ion channels as
well.
3.2. Material and Methods
3.2.1. Synthesis of 7a-7e
General Methods. The general synthetic methods for 7a-7e are the same as those
described for compounds la, ib, and 2-6 (see Chapter 2.2.1).
General Procedure for the Synthesis of Bivalent PEG-QA Conjugates (7a-7e).
The starting material (I-b, -120-140 mg, 1 equiv.) was dissolved in CH3CN (1.5 mL)
and was added the reacting tertiary amine (1.5 mL). The mixture was stirred at 25 °C (for
7a) or 75 °C (for 7b-7e) for 16-24 h. The solvent and the majority of amine were
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removed by rotary evaporation. The residue was purified by a short silica gel column to
provide the final product. The synthesis of the starting material I-b can be found in
Chapter 2.2.1.
Compound 7a: The bis(N-methylpyrrolidinium) salt 7a was prepared from diiodide I-b
(124 mg, 0.21 mmol) and N-methylpyrrolidine. The reaction was carried out at 25 "C for
24 h and the crude product was purified by silica gel chromatography (1:2.5
MeOH:CHC13) to provide 7a as a pale yellow solid (62 mg, 39%). 'H NMR (CD 30D,
300 MHz): 8 3.97 (m, 4H), 3.72-3.58 (m, 36H), 3.17 (s, 6H), 2.24 (br m, 8H); ' 3C NMR
(DMF-d7, 75 MHz): 6 71.3 (br, PEG backbone), 71.2, 71.0, 66.0, 65.9, 63.8, 49.4, 22.3;
HRMS-ESI (m/z) calcd for C26H54IN20 7 [M - I]+: 633.2970; found: 633.2977.
Compound 7b: The bis(N-methylpiperidinium) salt 7b was prepared from diiodide I-b
(139 mg, 0.24 mmol) and N-methylpiperidine. The reaction was carried out at 80 °C for
16 h and the crude product was purified by silica gel chromatography (1:3 MeOH:CHC13)
to provide 7b as a pale yellow solid (79 mg, 42%). 'H NMR (CD 30D, 300 MHz): 8 3.98
(br m, 4H), 3.74-3.62 (m, 28H), 3.55 (m, 4H), 3.50 (m, 4H), 3.22 (s, 6H), 1.94 (br m,
8H), 1.72 (m, 4H); 13C NMR (DMF-d7, 75 MHz): 6 71.3 (br, PEG backbone), 71.2, 70.9,
65.1, 63.0, 62.5, 49.8, 21.8, 20.8; HRMS-ESI (m/z) calcd for C28H58IN20 7 [M - I]+:
661.3283; found: 661.3256.
Compound 7c: The bis(N-ethylpiperidinium) salt 7c was prepared from diiodide I-b (124
mg, 0.21 mmol) and N-ethylpiperidine. The reaction was carried out at 75 °C for 18 h
and the crude product was purified by silica gel chromatography (1:2.5 MeOH:CHC13) to
provide 7c as a pale yellow solid (76 mg, 44%). 'H NMR (CD 30D, 300 MHz): 8 3.92
(br m, 4H), 3.70-3.54 (m, 32H), 3.54 (m, 4H), 1.92 (m, 8H), 1.72 (m, 4H), 1.33 (t, J=
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7.2 Hz, 6H); 13C NMR (DMF-d 7, 75 MHz): 6 71.3 (br, PEG backbone), 71.0 (2 peaks),
65.0, 60.2, 58.0, 56.0, 22.0, 20.6, 8.1; HRMS-ESI (m/z) calcd for C30H62IN20 7 [M - I]+:
689.3596; found: 689.3611.
Compound 7d: The bis(triethylammonium) salt 7d was prepared from diiodide I-b (141
mg, 0.24 mmol) and triethylamine. The reaction was carried out at 75 "C for 24 h and the
crude product was purified by silica gel chromatography (1:2.5 MeOH:CHC13) to provide
7d as a pale yellow solid (77 mg, 41%). 'H NMR (CD 3OD, 300 MHz): 6 3.89 (br m,
4H), 3.70-3.62 (m, 24H), 3.51 (m, 4H), 3.44 (q, J= 7.2 Hz, 12H), 1.31 (t, J= 7.2 Hz,
18H); 13C NMR (CD 30D, 75 MHz): 8 71.7, 71.6 (br, PEG backbone), 71.5, 65.6, 57.9,
55.0, 8.2; HRMS-ESI (m/z) calcd for C28 H62IN 20 7 [M - I]+: 665.3596; found: 665.3583.
Compound 7e: The bis(N-methyldipropylammonium) salt 7e was prepared from diiodide
I-b (124 mg, 0.21 mmol) and N-methyldipropylamine. The reaction was carried out at 75
C for 17 h and the crude product was purified by silica gel chromatography (1:2.5
MeOH:CHC13) to provide 7e as a pale yellow solid (72 mg, 42%). 'H NMR (CD 30D,
300 MHz): 6 3.92 (br m, 4H), 3.72-3.62 (m, 24H), 3.59 (m, 4H), 3.36 (m, 8H), 3.13 (s,
6H), 1.80 (m, 8H), 1.02 (t, J= 7.2 Hz, 12H); 13C NMR (DMF-d 7, 75 MHz): 6 71.2 (br,
PEG backbone), 71.0, 65.3, 64.6, 61.8, 49.6, 16.7, 11.1; HRMS-ESI (m/z) calcd for
C30 H66 IN 20 7 [M - I]+: 693.3909; found: 693.3915.
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Scheme 3.1. Synthesis of PEG-QA conjugates 7a-7e.
NR3
i 0_4 I O " l  QA 0-.Q O 
Q A
6 CH 3CN 6
I-b room temp. or 75 oC 7a-7e
7a (39%), NR3 = /-N3 7b (42%), NR3 = -N§ 7c (44%), NR3 = N
7d (41%), NR 3 =  -N 7e (42%), NR 3 = -N
3.2.2. Plasmids and Channel Expression
The adult, muscle-type AChR of mouse was transiently expressed in HEK-293
cells via calcium phosphate precipitation, as described in Chapter 2.2.2.
3.2.3. Electrophysiology and Data Analysis
The general methods for acquiring and detecting single-channel currents are the
same as those described in Chapters 2.2.3 and 2.2.4. In brief, single-channel currents
from adult mouse muscle AChR were recorded using patch-clamp techniques in the cell-
attached configuration. For agonist potency tests and dose-dependent measurements, a
holding potential of +70 mV was applied. The currents were amplified, low-pass filtered
at 10 kHz and digitized at 20 kHz. Event idealization (via SKM) and MIL fitting were
carried out using the QuB suite (www.qub.buffalo.edu). Because the blockade kinetics
were determined in the presence of 100 tM ACh (see Results), the model used in MIL
fitting is different from that used in Chapter Two. A model (Figure 3.4.B) which
includes both channel gating and desensitization is used for the dose- and voltage-
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dependent measurements (for a more in-depth illustration, see section 3.3.3). Recording
segments containing more than 500 opening events but no more than two simultaneously
open channels were chosen for analysis.
3.3. Results
3.3.1. Synthesis of Bivalent PEG-QA Conjugates (7a-7e)
The prototype molecules tested in Chapter Two were prepared via an SN2
substitution of the precursor PEG-iodides with trimethylamine at ambient temperature
(Chapter 2.2.1). The same chemistry was used for the preparation of 7a-7e, using
diiodide I-b as the precursor (Scheme 3.1). I-b was previously derived from
octa(ethylene glycol) for the synthesis of the prototype molecule 2 (Chapter 2.2.1).
Because molecules possessing small cyclic or acyclic QA groups were previously used in
pharmacological studies of muscular and neuronal AChR inhibition [15-17], five small,
commercially available tertiary amines were chosen to react with I-b: N-
methylpyrrolidine (for 7a), N-methylpiperidine (for 7b), N-ethylpiperidine (for 7c),
triethylamine (for 7d), and N-methyldipropylamine (for 7e). Although N-
methylpyrrolidine reacted well with I-b at room temperature, the remaining tertiary
amines showed only low or moderate reactivity under the same condition. The reaction
was therefore carried out at an elevated temperature in order to achieve higher yields of
7b-7e. However, the conversion remained incomplete after >12 h of reaction at 75 'C,
and colored byproducts formed over the course of the reaction. To obtain pure products
for electrophysiology experiments, crude 7a-7e were purified by silica gel
chromatography. Although the PEG-QA conjugates are charged and soluble in water,
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reverse-phase chromatography was not considered, due to the facts that PEG is highly
hygroscopic and that hydrated PEG-QAs may not be dried easily after purification.
Adsorption of PEG-QAs to normal phase silica gel caused substantial loss of products
during purification, but purified 7a-7e with satisfactory yields (-40%) were obtained by
minimizing the column size. Purification of PEG-QAs via recrystalization was not
successful because the crude products were fluid substances in most cases.
3.3.2. The Agonist Potencies of 7a-7e
Prior to studying the blockade kinetics of 7a-7e, the agonist potencies of these
compounds were tested. In the proof-of-concept study (Chapter Two), all of the tested
PEG-TMA conjugates were capable of inducing AChR openings in the absence of other
agonists such as acetylcholine (ACh) or carbamylcholine (CCh). Similarly, 7a-7e are
likely to activate the AChR because various QAs have been reported as agonists of the
muscle-type AChR [4, 7-11].
To test the agonist potencies of 7a-7e, single-channel currents from transiently
expressed AChRs were recorded in the presence of 10 CiM of each PEG-QA alone (in
pipette solution). The results in Chapter Two suggest that the frequency of channel
blockade would be low at 10 pM of PEG-QA (assuming that the blocking rate constants
of 7a-7e are comparable to that of the prototype molecule (compound 2 in Figure 3.2)).
Therefore, the observed AChR activities stimulated by 7a-7e, if any, are expected to be
close to those in the absence of blockade, allowing the agonist potencies of these
compounds to be compared.
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The agonist potencies of 7a-7e were studied in two aspects. First, we compared
the total fraction of time in which AChRs stay open during recording:
NP = "N iPo, (1)
where Nm,,x is the maximal number of simultaneously open channels and Po,i is the
fraction of time (relative to the total recording length) in which i channels open
simultaneously. The results are shown in Figure 3.3A and 3.3B. All of the tested
molecules are able to stimulate AChR openings, but channel activities vary in response to
different compounds (Figure 3.3A). NPo is the highest at 10 tM 7d, the compound
having a triethylammonium group at each end of PEG (NPo -10- 2, Figure 3.3B). The
AChR activity decreases an order of magnitude when the triethylammonium groups are
replaced by N-methylpyrrolidinium (7a) or N-methylpiperidinium (7b) (Figure 3.3B).
Although silent patches (i.e., patches in which no channel activity was found) occur
occasionally at all tested conditions (even in the presence of ACh), the chance of
obtaining silent recordings at 10 tM 7c (QA = N-ethylpiperidinium) or 7e (QA = N-
methyldipropylammonium) is relatively high, and the values of NPo estimated from
active recordings are very low (-10-5, Figure 3.3B).
Second, we compared the mean duration of openings stimulated by each
compound (Figure 3.3C). The mean open time (to) describes the lifetime of the openings
regardless of how frequently the channels open. The trend in mean open time is similar
to that in NPo, with 7d stimulating the most long-lived (To = 0.89 + 0.02 ms) events while
7c and 7e inducing the briefest openings (to = 0.19 + 0.02 and 0.22 + 0.14 ms,
respectively). At 10 tM 7c or 7e, the open durations are so short that many of them are
only partially resolved at our recording bandwidth. Both NPo and to indicate that 7c and
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7e are poor agonists for the muscle-type AChR. In summary, patch-clamp recordings at
10 jiM of 7a-7e reveal that the QA group plays an important role in defining a PEG-
QA's ability to activate the AChR.
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Figure 3.3. Effects of the QA structure on the activation of the AChR. (A) Representative traces
of single-channel recordings in the presence of 10 pM PEG-QA (without any other agonist). For
presentation, traces are filtered at 5 kHz and the currents are shown as upward deflections.
Pipette potential was held at +70 mV. (B) The effect of the QA structure on the AChR's open
probability (defined as NPo, see Equation 1 in section 3.3.2). The bars are plotted in log-scale for
a clearer visualization of the low NPo values. Only active recordings were pooled for statistics.
(C) The effect of the QA structure on the AChR's mean open duration. Error bars represent
standard deviations.
-113-
~;;;;;;;;;~ - - --
I h
3.3.3. Dose-dependent Blockade of the AChR by 7a-7e
Experimental Strategy. As shown in Chapter Two, all of the tested PEG-TMA
conjugates stimulated AChR activities at 5-500 pM, and therefore the characterization of
blockade kinetics was carried out without the addition of other agonists such as ACh or
CCh. The same approach may not be suitable for the characterization of blockade
kinetics for 7a-7e. First, 7c and 7e are poor agonists for the muscle-type AChR (Figure
3.3), and therefore measurements at low concentrations of these compounds are difficult.
Second, to of the tested PEG-QAs are small, ranging from 0.4-0.2 ms at 10 pM (with the
exception of 7d). If the tested molecules block the pore at a rate comparable to that of the
prototype compound (36 iM-ls-'), opening events at higher concentrations of these PEG-
QAs would be too short to be detected precisely. For instance, to would be -0.2 and -0. 1
ms at 100 jiM of 7a and 7e, respectively, values very close to our detection limit. A great
fraction of opening events would therefore be missed or only partially resolved. Taken
together, dose-dependent measurements for 7a-7e would not be feasible at either high or
low concentration ranges without the aid of other agonists.
For 7a-7e, the dose dependence of blockade was examined by analyzing single-
channel currents at 100 pM ACh in the absence and presence of 5, 10, or 20 pM of PEG-
QA. Similar approaches were previously used to study AChR blockade by pyrantel [18]
and tacrine [19]. Under these conditions, AChRs are expected to be activated
predominately by ACh due to its excess dose and high potency (EC 5o = 28 pM) [20]. The
fraction of openings induced by PEG-QA is expected to be low, allowing an
unambiguous characterization of blockade behavior for 7a-7e.
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Channel Behavior under the Control Condition. At 100 tM ACh, the AChR is
mostly desensitized (i.e., the channel binds agonists with a high affinity but assumes a
non-conducting conformation). Once recovered from desensitization, the AChR
undergoes cycles of opening and closing, due to rapid reactivation of the closed channel
by the high dose of ACh, before reentering the desensitized state. Single-channel
currents are displayed as clusters of openings separated by long closed dwells (Figure
3.4A). The long dwells are desensitization periods, while the brief gaps within the
clusters represent channel closing events. For the data obtained under this condition, the
closed-time distribution requires at least four exponential components for MIL fitting,
which is consistent with the previously reported observations [Ref 19 and references
therein]. The lifetimes of these components are: <1 ms (fastest component), -5 ms, -50
ms, and -1 s (slowest). In some recordings where channel activity is very low, a fifth
component (lifetime >1 s) is present. Prince et al. reported two fast components whose
lifetimes are less than 1 ms (-20 jps and -100 )ps), but we were not able to isolate the 20-
ips component due to our recording bandwidth (10 kHz). The 100-ps component reported
in the study by Prince et al. was believed to arise from dwells of the closed states
(including unliganded, monoliganded, and biliganded closed states), and the longer-lived
components were reported as desensitized components [19]. Here we designate the
closed-time components as C (closed, lifetime <1 ms), D 1 (fast desensitized, lifetime -5
ms), D2 (intermediate desensitized, lifetime -50 ms), and D3 (slow desensitized, lifetime
-1 s) states in our kinetic model for MIL fitting (Figure 3.4B and 3.4C). The histogram
of the open durations can be reasonably fitted by a single-exponential distribution (Figure
3.4C) with a lifetime of 4.1 ± 1.3 ms (mean ± S.D., 4 trials).
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Figure 3.4. Characterization of single-channel currents at 100 jiM ACh (i.e., the control
condition). (A) Representative traces. Currents are shown as upward deflections. Pipette
potential was held at +70 mV. (B) The kinetic model used for fitting the single-channel events
(by MIL). C, closed state; 0, open state; DI, D2, D3, desensitized states (ranked in the order of
increasing lifetime). (C) Representative histograms for the closed-time (left) and the open-time
(right) distributions. Each component in the closed-time histogram is designated by the
corresponding state in the kinetic model. The solid curves represent the overall fit for the
histogram, and the red dashed curves indicate the fits for individual components.
As illustrated in Chapter Two, a simple mechanism of sequential open-channel
blockade predicts a dose-dependent decrease in the apparent mean open time and the
presence of a "blocked" component in the closed-time histogram. The relative area of the
blocked component increases with increasing blocker concentration, but the lifetime (CB)
of this component is independent of blocker concentration. As shown in Figure 3.4C, the
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events in the closed-time histogram arise mainly from the brief channel-closing dwells
(C) at 100 piM ACh and the relative areas of the desensitized components are small. If TB
is larger than the lifetime of the closed-state component (C), the blocked component can
be easily identified. Moreover, fitting the closed- and open-time histograms (by MIL)
provides the transition rates between states. The blocking rate (i.e., the rate at which the
open channel enters the blocked state) is predicted to be proportional to the blocker
concentration, but the unblocking rate is concentration-independent. The dose-dependent
effects of each PEG-QA on the AChR currents were studied through the analysis of the
open- and closed-time distributions as well as the microscopic rates estimated from MIL
fitting. The results of single-channel analysis for 7a-7e are presented below and
summarized in Figures 3.5-3.10.
Dose-Dependent Decrease in the Apparent Mean Open Time. Whether 7a-7e
block the open AChR was first examined by measuring the mean duration of AChR
openings (stimulated by 100 jtM ACh) in the presence of 0, 5, 10, and 20 jtM PEG-QA.
At high concentrations of ACh, one general concern about measuring 'o is that the
reopening rate of the closed channel is very fast, leading to transient closed dwells that
are often poorly resolved. The unresolved closings between successive openings would
lead to an overestimation of to. However, it was previously demonstrated that correction
of to is not necessary for describing the dose-dependent change in the open durations
under our experimental conditions [19]. The reciprocal of the apparent mean open time
(Ta,, the mean open time estimated from MIL fitting without missed-event correction),
like that of zo, follows a linear relationship with blocker concentration:
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where Tz,, is the apparent to in the absence of the tested PEG-QA and k+app is the
apparent blocking rate constant.
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Figure 3.5. Decrease of the open durations in the presence of PEG-QA conjugates. (A)
Representative traces at 100 pM ACh in the absence (i.e., control) and presence of 20 pM PEG-
QA. Currents are shown as upward deflections. Pipette potential was held at +70 mV. (B)
Determination of apparent blocking rate constant (k+app) by fitting the plot of 1/zapp vs. [PEG-QA].
The value of k+app for each compound, which is given by the slope of the linear fit, is listed in
Table 3.1. Tapp, apparent mean open time determined by MIL fitting of the open-time histogram.
Error bars indicate standard deviations.
As shown in Figure 3.5, the durations of channel openings decrease in the
presence of each tested PEG-QA. Under the control condition (100 gtM ACh), opening
events group into clusters, and the Tapp is 4.1 ± 1.3 ms. In the presence of 20 gtM 7a, the
openings remain clustered, but they are chopped into briefer events by several gaps,
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leading to lengthened clusters (Figure 3.5A). In the presence of 20 pM 7b-7e, clustered
openings are not found, but the durations of individual openings are briefer compared to
those under the control condition (Figure 3.5A). The plots of l/Tapp vs. [PEG-QA] for
7a-7e can all be fitted linearly (Figure 3.5B). The values of k+app for these compounds
can be extracted from the slope of the linear fits (in pM'ss'): 38 ± 3 (7a), 44 ± 6 (7b), 27
± 4 (7c), 26 ± 5 (7d), and 20 ± 4 (7e). The observed linear relationships between l/Tapp
and [PEG-QA] suggest that 7a-7e are all capable of interrupting open-state currents,
presumably via binding within the AChR pore. Moreover, the k+appS for 7a-7e are all
comparable to the k+B of their prototype blocker (compound 2, 36 ± 6 M-'s-l), indicating
that small modifications in the end-group structure do not significantly affect the rate of
blocker association. The open-time histogram remains a single-exponential distribution
in the presence of PEG-QA but shifts toward a shorter lifetime (part B of Figures
3.6-3.10).
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Figure 3.6. Characterization of AChR blockade at various concentrations of 7a. (A)
Representative histograms of closed-time distributions. (left) 100 piM ACh ± 5 pM 7a; (right)
100 pLM ACh + 5 and 20 .M 7a. Arrows indicate the the putative blocked components. Two
putative blocked components were found, and they were designated as "major" and "minor"
components based on the magnitude of their entry rates (part C). (B) Representative histograms
of open-time distributions at 100 pM ACh in the absence (i.e., control) or presence of 20 pM 7a.
(C) Dose-dependent increase in the rate of entering each putative blocked state. The linear plot of
1/,app vs. [7a] (used for determining k+app) is included for comparison. (D) The rate of departing
from each putative blocked state at 5, 10, and 20 p.M of 7a. Pipette potential was held at +70 mV.
Error bars indicate standard deviations. The determination of blocking and unblocking rate
constants (k+B and k-B), as well as their values, can be found in the text and Table 3.1.
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Figure 3.7. Characterization of AChR blockade at various concentrations of 7b. (A)
Representative histograms of closed-time distributions. (left) 100 pM ACh ± 5 pM 7b; (right)
100 IM ACh + 5 and 20 pM 7b. Arrows indicate the putative blocked components. Two
putative blocked components were found, and they were designated as "major" and "minor"
components based on the magnitude of their entry rates (part C). (B) Representative histograms
of open-time distributions at 100 pM ACh in the absence (i.e., control) or presence of 20 IpM 7b.
(C) Dose-dependent increase in the rate of entering each putative blocked state. The linear plot of
1/avpp VS. [7b] (used for determining k+app) is included for comparison. (D) The rate of departing
from each putative blocked state at 5, 10, and 20 pM of 7b. Pipette potential was held at +70
mV. Error bars indicate standard deviations. The determination of blocking and unblocking rate
constants (k+B and k-B), as well as their values, can be found in the text and Table 3.1.
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Figure 3.8. Characterization of AChR blockade at various concentrations of 7c. (A)
Representative histograms of closed-time distributions. (left) 100 iM ACh ± 5 pLM 7c; (right)
100 pM ACh + 5 and 20 pM 7c. Arrows indicate the putative blocked components. Two
putative blocked components were found, and they were designated as "major" and "minor"
components based on the magnitude of their entry rates (part C). (B) Representative histograms
of open-time distributions at 100 pM ACh in the absence (i.e., control) or presence of 20 pM 7c.
(C) Dose-dependent increase in the rate of entering each putative blocked state. The linear plot of
1/app vs. [7c] (used for determining k+app) is included for comparison. (D) The rate of departing
from each putative blocked state at 5, 10, and 20 pM of 7c. Pipette potential was held at +70 mV.
Error bars indicate standard deviations. The determination of blocking and unblocking rate
constants (k+B and k-B), as well as their values, can be found in the text and Table 3.1.
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Figure 3.9. Characterization of AChR blockade at various concentrations of 7d. (A)
Representative histograms of closed-time distributions. (left) 100 pM ACh ± 5 PM 7d; (right)
100 pM ACh + 5 and 10 pM 7d. Arrows indicate the putative blocked components. Two
putative blocked components were found, and they were designated as "major" and "minor"
components based on the magnitude of their entry rates (part C). (B) Representative histograms
of open-time distributions at 100 pM ACh in the absence (i.e., control) or presence of 10 pIM 7d.
(C) Dose-dependent increase in the rate of entering each putative blocked state. The linear plot of
1/zapp vs. [7d] (used for determining k+app) is included for comparison. (D) The rate of departing
from each putative blocked state at 5, 10, and 20 pM of 7d. (E) A representative histogram for
the distribution of closed dwells at 100 pM ACh and 20 pM 7d. In addition to the two blocked
components (lifetimes -50 ms and -1 s), a third component arises with a life time of -200 ms.
Pipette potential was held at +70 mV. Error bars indicate standard deviations. The determination
of blocking and unblocking rate constants (k+B and k), as well as their values, can be found in
the text and Table 3.1.
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Figure 3.10. Characterization of AChR blockade at various concentrations of 7e. (A)
Representative histograms of closed-time distributions. (left) 100 PrM ACh ± 5 jM 7e; (right)
100 pM ACh + 5 and 20 pM 7e. The arrow indicates the putative blocked component. Only one
putative blocked component was found. (B) Representative histograms of open-time distributions
at 100 p1M ACh in the absence (i.e., control) or presence of 10 pM 7e. (C) Dose-dependent
increase in the rate of entering the putative blocked state. The linear plot of 1/trpp vs. [7e] (used
for determining k+app) is included for comparison. (D) The rate of departing from the putative
blocked state at 5, 10, and 20 pM of 7e. Pipette potential was held at +70 mV. Error bars
indicate standard deviations. The determination of blocking and unblocking rate constants (k+B
and k-B), as well as their values, can be found in the text and Table 3.1.
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Identification of the Blocked Components, Blocking Rate Constants, and
Unblocking Rate Constants. From the recording traces with 7a (Figure 3.5A), it is clear
that the open-state currents are chopped by a new population of non-conducting events,
indicating the presence of the blockade events. However, the indication of the blockade
events is less evident in the presence of 7b-7e since opening events are not clustered but
sparsely separated. The blockade events were identified by comparing the closed-time
histograms at various concentrations of PEG-QAs (with 100 tM ACh). According to the
sequential open-channel blockade model (Equation 3 in Chapter 2.2.4), the blocked
component should comprise two basic features: (1) the relative area of this component
increases with increasing [PEG-QA]; and (2) the lifetime of this component is
independent of [PEG-QA] [2, 18]. Microscopic rates of transitioning between different
states of the AChR, estimated by MIL fitting, also provide important clues for identifying
the blocked component. Based on the sequential blockade model, the rate of entering the
blocked state (i.e., k+B[B]) is proportional to blocker concentration, while the rate of
departing from the blocked state (i.e., k-B) is dose-independent.
From the analysis of closed-time distributions and microscopic transition rates,
the blocked components in the presence of 7a-7e were identified (Figures 3.6-3.10).
Surprisingly, four of the five compounds (7a-7d) were found to exhibit two modes of
blockade. In both modes, the rate of entering the putative blockade state increases
linearly with [PEG-QA] and the departing rate is not sensitive to [PEG-QA], consistent
with the characteristics of open-channel blockade (part C and D of Figures 3.6-3.9). The
blocking rate constant (k+B) for each mode, estimated as the slope of the linear fit for the
entry rate vs. [PEG-QA] plot, is smaller than k+app estimated from the 1/Tapp VS. [PEG-
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QA] plot (part C of Figures 3.6-3.9). However, the sum of the two k+Bs is very close to
k+app (Table 3.1), suggesting that both modes contribute to the observed dose-dependent
decrease in the apparent mean open time, and that the two blocked states are entered from
the same open state.
Because we did not observe a dose-dependent change in the unblocking rate (i.e.,
the rate of departing from the putative blocked state) for either mode, the unblocking rate
constant (kL) for each mode was calculated by averaging the unblocking rates measured
at all tested concentrations. The k+B and kB values for the two blockade modes of 7a-7d
are listed in Table 3.1. For clarity, the blockade mode having the higher k+B is designated
as the "major" mode, and the one with the lower k+B is designated as the "minor" mode.
The k+B of the major mode is around 20-30 tMl's-', and the k+B of the minor mode is -10
tM' ls ~ or lower. For 7a-7d, the dose-dependent increase in the relative area of the
major blocked component can be easily observed in the closed-time histogram (part A of
Figures 3.6-3.9). The minor blocked component is not significant in the closed-time
histograms, but the dose-dependent increase in the entry rate of another non-conducting
state is observed, supporting the presence of the second blocked component.
Interestingly, the two k_ values for 7a-7d are very similar: the faster kLB is 45-85 s1,
and the slower ks is 2-4 s '. Compound 7a behaves particularly differently from 7b-7d
in that its major mode of blockade exhibits faster dissociation (k -B= 64 ± 14 s-'), whereas
7b-7d carry out slower dissociation in their major blockade mode (k = 2-4 s-').
Blockade at 20 tM 7d becomes more complex. As shown in Figure 3.9E, a new
closed-time component arises with a lifetime (-200 ms) intermediate between those of
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the two preexisting blocked components (-50 ms and -1 s). In addition, the relative area
of the major component at 10 CtM does not further increase at 20 pM. These observations
indicate that other modulation(s) of the AChR may take place at higher concentrations of
7d.
Blockade by 7e is not as complex as blockade by 7a-7d. Only one blocked
component was found, and the values of k+B (from the linear fitting of blocking rates vs.
[PEG-QA]) and k+,pp are similar (Figure 3.10 and Table 3.1). The k+B and k-B for 7e are
15 ± 1 p.M -'s-1 and 2 ± 1 s- , respectively, giving a dissociation constant for blockade
(Kd) of 0.12 ± 0.09 pM. The IQs for the major blockade mode of 7a, 7b, 7c, and 7d are
3 ± 1, 0.08 ± 0.09, 0.17 ± 0.12, and 0.19 ± 0.15 pM, respectively. The KI for the minor
blockade mode are 0.30 ± 0.17, 4 ± 2, 16 ± 9, and 9 ± 7 p.M, respectively. For
comparison, the Kds of the prototype molecule (2) is 9 + 2 pM.
Although the blockade events manifest themselves as a distinct new component in
the closed-time histogram, it is worth noting that the blocked components overlap with
the desensitized components and may not always be resolved successfully by MIL fitting.
However, our results show that the contamination of the blocked components by
desensitization events would not be intractable, at least for the major component, at all
tested concentrations (5-20 pM). Comparing the closed-time histograms at 100 p.M ACh
+ 5 p.M of the tested PEG-QA, the fraction of the blockade events (major component) at
5 p.M PEG-QA is significantly larger than the fractions of the desensitization events (part
A of Figures 3.6-3.10). Although the minor blocked components are less observable in
the closed-time histograms and are indeed not separated from the desensitized
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components by MIL fitting, the dose-dependent increase in the blocking rate (extracted
from MIL) allows us to identify k+B unambiguously for the minor mode.
Table 3.1. Blockade Rate Constants and Equilibrium Dissociation Constants for 7a-7e.
major mode minor mode
k+app k+B k-s Kd k+B k-s Kd
name QA (M-s-)a ( M-'s'I)b (s-)c (M)d ( -'Is'1) ( 1 ) (pIM)
7a -- N 38 3 204 644 3 ±1 7 1 2 1 0.30(n 8) (n =8) ± 0.17
2 + 2 0.08 54 + 207b - No 44 + 6 29 ± 7 0.0 13 + 1 54 4 2
(n 9) ± 0.09 (n = 9)
7e 27-N 4 22 2 0.17 45 36 169
(n= 8) + 0.12 (n= 8)
- - _ 4 + 3 0.19
7d 26 ±5 22 (n =6) + 0.15 5 2 (n = 9)
2 1 0.127e -- N _ 20 + 4 15 + 1 N. D.
/ (n = 8) ± 0.09
339 + 782 --- N- 36 1 3 9+ 2 N. D.
(n = 15)
(a) The apparent blocking rate constant (k+app) was determined from the slope of the linear fit for 1/Tapp vs.
[PEG-QA] plot.
(b) The blocking rate constant (k+B) was determined from the slope of the linear fit for blocking rate vs.
[PEG-QA] plot. The blocking rate, defined as the rate of entering the putative blocked state, was
extracted from MIL fitting.
(c) The unblocking rate constant (k) was calculated by averaging the unblocking rates measured at all
tested concentrations. The unblocking rate, defined as the rate of departing from the putative blocked
state, was extracted from MIL fitting.
(d) Kd is defined as ks/ kB.
(e) Error bars represent standard deviations. N. D., not determined.
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3.3.4. Voltage Dependence of Blockade
To determine whether 7a-7e target the AChR pore, we measured Tapp, k+B and k_B
at various transmembrane voltages (Figure 3.11). As described in Chapter Two, the
prototype molecule (2) blocks the AChR in a voltage-dependent manner. The blocking
rate by compound 2 increases with hyperpolarization (i.e., more negative transmembrane
voltage), and the ln(k+B) vs. Vm (membrane potential) plot follows a linear relationship,
allowing us to estimate the binding site for compound 2 from the linear fit. Because two
modes of blockade were found for 7a-7e, one exhibiting a faster dissociation (kB =
45-85 s- ') than the other (k-B = 2-4 s-'), we characterized the voltage dependence of tapp,
k+B, and k-B for 7a, 7c, and 7e. These compounds represent three types of blockade
preference: 7a prefers the faster dissociation mode, 7c prefers the slower dissociation
mode, and 7e only exhibits the slow dissociation mode. In order to identify the blocked
component unambiguously, the measurements were carried out at 20 pM of each PEG-
QA accompanied by 100 pM ACh, and the major blocked components (of 7a and 7c)
were chosen for the analysis of k+s and k-_. Within the range of the membrane potentials
tested (-60 to -160 mV), all three compounds cause more abbreviated TappS with
hyperpolarization (Figure 3.11A), indicating that blockade frequency increases at more
negative voltages. The increase of k+B with hyperpolarization further supports this
hypothesis (Figure 3.11B). The plots of ln(k+B) vs. Vm were fitted by least-squares linear
regression, and the slopes of the linear fits were used to estimate the electric distance 6
(i.e., the fraction of the total transmembrane voltage drop a blocker experiences when
traveling to the binding site from the extracellular vestibule). A detailed illustration of
the calculation can be found in Chapter 2.3.2. In brief, the slope equals -zSF/2RT, where
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z is the charge of the blocker, F is Faraday's constant, R is the gas constant, and T is the
absolute temperature [7, 21, 49, 50]. Because the molecules have two QA groups, z is
assumed as 2, and the values of 8 for 7a, 7c, and 7e are estimated as 0.28 (1 trial), 0.29 +
0.00 (2 trials), and 0.23 ± 0.01 (2 trials), respectively (mean + S.D.). The values of 8
calculated for 7a, 7c, and 7e are very close to that of the prototype molecule (8 = 0.25 ±
0.06), suggesting that these PEG-QAs reach the same depth of the transmembrane region
and are likely to share the same binding site within the channel. Similar to the
observation for the prototype molecule, the dissociation rates of 7a, 7c, and 7e are not
sensitive to Vm changes until the membrane is highly hyperpolarized (Figure 3.11C). The
results show that the voltage dependence in blockade is not affected by the structure of
the QA or the preference in blockade mode (faster vs. slower dissociation).
The voltage dependences in the rates of entering and departing from the
desensitized states were also examined. The results for D2 and D3 states, whose lifetimes
are close to the faster- and slower-dissociation blocked components, are shown in Figure
3.12. Neither of the entry rates increases progressively with hyperpolarization, and their
values remain low (10-30 s-') compared to the blocking rates (>250 s-') determined at all
tested voltages. The results indicate that channel desensitization would not cause
interference with the analysis of voltage dependences of blockade kinetics.
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Figure 3.11. Voltage-dependences in AChR blockade at 20 ItM of 7a, 7d, and 7e. (A)
Representative plots of Tpp vs. membrane potential. (B) Representative plots of ln(k+B) vs.
membrane potential. The data were fitted by least-squares linear regression in order to estimate
the electric distance 8 (see text). (C) Representative plots of ln(k) vs. membrane potential. The
ln(k+B) and ln(k) values from the major blockade modes of 7a and 7c were plotted. Note that
the y-axes in (A) and (B) are truncated in order to highlight the data.
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Figure 3.12. Lack of voltage dependence in the transition rates between open and
intermediate/slow desensitized states in the absence of PEG-QA. (A) Rates of entering (left) and
departing from (right) the intermediate desensitized state (D2) at various transmembrane voltages
(100 pM ACh). (B) Rates of entering (left) and departing from (right) the slow desensitized state
(D3) at various transmembrane voltages (100 p.M ACh).
3.4. Discussion
In this chapter, we investigate whether the quaternary ammonium groups of a
PEG-QA conjugate play an important role in the activation and blockade of the AChR.
We find that small structural modifications in QA may have profound effects on a PEG-
QA's blockade kinetics, affinity, or agonist potency. Replacement of the
trimethylammonium groups in the prototype blocker with other cyclic or acyclic QAs
greatly enhances the blocker's affinity. The blockade mechanism and the effects of the
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QA structure on AChR activation/blockade are discussed, and a working model for PEG-
QAs is proposed.
3.4.1. Mechanism of Blockade
Analyses of single-channel currents at various doses of PEG-QAs and voltages
support the hypothesis that 7a-7e block the open AChR. All of these PEG-QAs cause a
dose-dependent decrease in the durations of AChR-induced currents, and the 1/tapp vs.
[PEG-QA] plots are linear (Figure 3.5B). Through MIL analysis, the blocking rates of
7a-7e are found to increase linearly with increasing [PEG-QA], but the unblocking rates
(or the lifetimes of the blocked components) do not vary systematically with [PEG-QA]
changes (Figures 3.6-3.10). All of these observations are consistent with the
characteristics of sequential open-channel blockade (Equation 3 in Chapter 2.2.4) [2, 18,
19]. Voltage-dependent increase in the blocking rates of 7a, 7c, and 7e suggest that
binding sites of the PEG-QAs are located within the transmembrane part of the AChR.
The electric distance 6, which measures the fraction of the transmembrane electric field
experienced by the blocker when traveling to the binding site, provides a rough estimate
for the binding site location. For the tested PEG-QAs, 6 is 0.2-0.3, indicating that these
charged molecules can reach as deeply as 20-30% into the membrane from the
extracellular side. Assuming that the thickness of cell membrane is -40 A, the binding
sites would be -8-12 A deep.
Some compounds, such as steroid-like molecules, were previously proposed to
bind non-luminal sites and allosterically inhibit AChR currents in a dose- and voltage-
dependent manner [22-25]. However, we believe that 7a-7e are more likely to occupy
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the transmembrane lumen and sterically impede current flows. Due to the permanently
charged QAs and the hydrophilic PEG backbone, it would be thermodynamically
unfavorable for PEG-QAs to reach a non-luminal site (such as the interior of the lipid
bilayer or the lipid-protein interface) which is -10 A deep inside the cell membrane. The
transmembrane lumen, which is connected to the ion-conducting extracellular vestibule
of the AChR, is the most accessible region for PEG-QAs.
Although the blocked and desensitized components share similar lifetimes, our
results indicate that they are distinct in nature. Desensitization is not strongly voltage-
dependent (Figure 3.12 and Ref. 26), which is different from the observed voltage-
dependent transitions associated with the blocked components (Figure 3.11). Therefore,
it is less likely that PEG-QAs bind outside of the pore region and dose-dependently
induce AChR desensitization. The enhancement of AChR desensitization was proposed
to be insensitive to membrane potential changes in the previous characterization of AChR
inhibition by tricyclic antidepressants [27]. The authors found that long-lived
desensitization and slow open-channel blockade cannot be distinguished in single-
channel and macroscopic measurements if k-B is slower than 15 s'1. However, two
additional lines of evidence support an increase in channel desensitization as the
mechanism of antidepressant-mediated inhibition: the effects were not voltage-dependent
and the affinity of ACh for the agonist sites was enhanced in the presence of tricyclic
antidepressants [27]. In an earlier study of AChR blockade by tacrine, neither closed- nor
open-channel blockade by tacrine affected ACh affinity [19]. Therefore, in addition to
the voltage dependence of the inhibitory effects, the affinity of ACh to the agonist sites
may allow us to distinguish whether 7a-7e enhance AChR desensitization. Finally, we
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cannot rule out that the blocked channels are able to undergo channel closing or
desensitization. An in-depth analysis with more detailed kinetic models is required for
the examination of blockade-induced closing or desensitization.
3.4.2. A Comparison of PEG-QAs with Other AChR Blockers
The five PEG-QAs (7a-7e) studied in this chapter show strikingly high affinity to
the open AChR compared to the majority of the previously characterized open-channel
blockers for this channel. Although many ammonium compounds have been reported to
block the open AChR, most of their Ks are within micromolar or millimolar ranges and
their kBs are high (>200 s') (Table 2.2). To our knowledge, few slow-dissociation
blockers have been characterized by electrophysiological methods. Based on the
blockers' blockade kinetics and affinities, AChR blockade by 7a (major mode) is
comparable to blockade by the well-known local anesthetics QX-314 (k+B = 19 lM I s-1,
k-B -30 s l, and Kd --1 pM) [2] and nonoxime bispyridinium SAD-128 (k+B = 75-100
ipM's-' , k_B = 90-250 s-', and Kd = 0.9-3.3 piM) [30] (Figure 3.15). The k-Bs for MK-
801 (48 s-') [31] and ketamine (100 s-') [32], determined by macroscopic measurements,
are also close to that of 7a (Figure 3.15). The major blockade mode of 7b-7e may be
similar to the long-lived blockade by quinine [14] (Figure 3.15). Quinine causes a dose-
dependent decrease in to at 1 pM ACh, giving a k+B of 45 pM-'s'as estimated by
1/to-[quinine] correlation. Although a specific value of k-B was not provided by the
authors, a dose-dependent increase in the relative area of a slow component (lifetime =
1.4-2.7 s at 5-25 pM)) was reported, indicating the presence of the blocked state [14].
Using this lifetime, the k_ of quinidine is estimated as 0.4-0.7 s-', which is lower but
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close to the kBS of 7b-7e (2-4 s-). Slow open-channel blockade was also reported for
(+)-tubocurarine (Figure 3.15), which is better known as a competitive antagonist for the
AChR. Through the analysis of end-plate current decay [13] and ensemble currents in
out-side-out patches [12], the ks of (+)-tubocurarine was determined as 0.3 and 0.8 s-1,
respectively. These intermediate-slow dissociation blockers all contain one or more
hydrocarbon/aromatic rings and are considered to be structurally rigid, but they do not
share a general scaffold.
Our results demonstrate that, by simply linking two QA groups with an
appropriately sized PEG, a new type of blocker with low- to sub-micromolar affinitiy can
be prepared. These PEG-QAs are expected to have different physical properties from
those of the previously reported high-affinity blockers (Figure 3.15) in that they are
permanently charged and have a flexible scaffold. Such unique features might be
beneficial in several aspects. Some open-channel blockers are known to target not only
the open pore but also other non-luminal sites in the AChR or the cell membrane due to
their rigid and highly hydrophobic structure [25]. In addition, blockers without a
permanent charge might also enter the cell and block the AChR from the intracellular
side, leading to complicated blockade behavior. Because PEG-QAs are composed of two
permanent positive charges and a hygroscopic backbone, they may be less likely to target
the lipid bilayer or lipid-protein interfaces and are considered to be impermeable to the
cell membrane. More experiments will be required to test these features.
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Figure 3.13. Structure of some previously reported open-channel blockers for the AChR with an
intermediate or low k-B.
3.4.3. Effects of the QA Structure on AChR Blockade
Our results show that the tested PEG-QAs mediate two modes of blockade, one
dissociates at 45-85 s-1 and the other at 2-4 s-', and the frequency at which each mode
occurs is affected by the structure of the QA groups (Table 3.1 and Figure 3.14). The
effect is likely correlated to the size of the QA: the contribution of the faster dissociation
mode decreases with increasing size of the QA. Compound 7a, which has the smallest
QA (N-methylpyrrolidium) among the five tested compounds, prefers the faster
dissociation mode. Interestingly, when the ring size of N-methylpyrrolidinium is
expanded by one carbon (7b), the slower dissociation mode becomes prevalent, but the
k+Bs of the two modes are still comparable. The k+B of the faster dissociation mode
further decreases when the methyl groups in 7b are replaced by ethyl groups (7c), but the
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k+B of the slower dissociation mode decreases only slightly. A similar trend can also be
found with acyclic QAs. The faster dissociation mode is infrequent but evident with 7d
(QA = triethylammonium, 6 carbons), but this mode is not observable with 7e (QA =
methyldipropylammonium, 7 carbons).
A B
i faster dissociation 401 faster dissociation
a slower dissociation ~ slower dissociation
100 30-CA
0.1 0
7a 7b 7c 7d 7e 7a 7b 7c 7d 7e
QA: -FNc 4-po - F, QA: NJ-N -F-H~
Figure 3.14. The effects of the QA structure on blocking and unblocking rate constants. (A) A
comparison of the unblocking rate constants (ks) for 7a-7e. The values of k-_ are plotted in log-
scale for a clearer visualization of the slower dissociation components. (B) A comparison of the
blocking rate constants (k+B) for 7a-7e. Faster and slower dissociation modes are designated
according to the relative amplitudes of the k_Bs.
For 7a-7d, the apparent blocking rate constant (k+,pp) is larger than the k+B of
either blockade mode but is close to the sum of the two k+s (Table 3.1). Because k+app is
determined from the dose-dependent decrease in the apparent mean open time, we believe
that both modes of blockade contribute to the abbreviation of the apparent open
durations. In addition, the structure of the QA does not seem to affect the k-s in either
mode. Analogously, in a previous single-channel analysis of a-hemolysin blockade by
Movileanu et al., free PEGs were also found to cause two classes of blockade event [51].
The authors proposed that the two classes of blockade events might arise from binding of
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PEGs with different conformations. When entering the pore, some PEG molecules may
adopt hairpin-like structures to have both ends near the entrance, whereas other PEG
molecules may first thread one end into the pore. A similar working model might be
applicable to our observations (Figure 3.15). Before entering the AChR pore, PEG-QAs
may dynamically transition among different conformations. In some conformations, the
two end groups are close to each other, while they are more separated in other
conformations. The ability of a PEG-QA to partition into the transmembrane lumen may
be different depending on the type of conformation it adopts when entering the pore. The
conformation of a PEG-QA inside the transmembrane lumen, which determines the
blocker-pore interactions, may also be affected by the conformation with which the PEG-
QA enters the pore. More studies are required to test the proposed model.
<blocked>
<closed> <open> PEG-QA
ACh
PE-QA
<blocked>
<desensitized>
Figure 3.15. A proposed working model for PEG-QAs (7a-7e). Some PEG molecules may
adopt conformations that have the end groups close to each other, while other PEG molecules
may have the two ends more separated. The two types of conformations, shown in green and
brown, may have different abilities to partition into the AChR pore and lead to different blocker-
pore interactions.
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The blockade affinities of 7a-7e are all higher than that of their prototype
molecule (2, QA = trimethylammonium) (Table 3.1). Although 7a-7d exhibit two modes
of blockade, the recording traces and closed-time histograms show that the effects of
these compounds on AChR currents mainly arise from the major blockade mode. In
order to simplify the comparison, we evaluate the affinities of 7a-7d only with their
major-mode Kds, but it should be noted that their true affinities are underestimated in this
way. The results show that the blockade affinity of a PEG-QA enhances -3-fold when
the trimethylammonium groups (2) are replaced by N-methylpyrrolidinium groups (7a)
(Kd: 9 - 3 pM). The affinity can be further enhanced, up to -100-fold, by replacing the
trimethylammonium groups with larger QAs such as N-methylpiperidinium (7b), N-
ethylpiperidinium (7c), triethylammonium (7d), and N-methydipropylammonium (7e)
(Kd: 9 pM - 80-190 nM). However, the effects on Kd caused by the these larger
substitutions are similar. Comparing the blockade kinetics of compound 2 and 7a-7e, we
find that the difference in blockade affinity arises mainly from the variation in k-B. The
changes in k+B are small, and the values of k+B are all within the same order of magnitude
(15-36 pM-ls-1). This is consistent with our earlier prediction, in which the k+B of a
PEG-QA is predominately determined by the spacer size if the modification in the QA
structure is small relative to the PEG length. The k+Bs of compound 2 and 7a-7e
therefore provide additional support for one of the major hypotheses in Chapter Two: the
k+B of a PEG-QA conjugate is determined by the entropic cost of confining PEG into the
AChR pore.
The comparison between compound 2 and 7a-7e shows that small modifications
in QA structure cause moderate to large changes in k-B and Kd. However, the magnitude
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of the effect does not seem to increase progressively with the size of the QA. The effect
is significant only when the comparison is made for compound 2 vs. 7a-7e or for 7a vs.
7b-7e. In a previous study of IEM-series blockers, Antonov et al. reported that replacing
the ammo group of IEM-1754 with trimethylammonium, isopropyldimethylammonium,
and tert-butyldimethylammonium only lead to a marginal change in the blockade kinetics
and affinity [5]. The lack of sensitivity of blockade to the QA structure was likely due to
the scaffold, 5-(1-adamantanemethylammonio)pentane, playing the principal role in pore
binding. The binding site of IEM-1754, described by 6, was estimated as 0.2-0.3.
Analogously, the 6 of our tested PEG-QAs is also 0.2-0.3, and there are only marginal
differences in the k_B and Kd of 7b-7e (major blockade mode). Taken together, it is
likely that a scaffold shared by 7b-7e serves as the principal binding element for PEG-
QAs derived from octa(ethylene glycol). Subtle extension from this principal scaffold is
tolerated by the AChR pore but does not provide additional blocker-channel interactions.
It is unclear yet what leads to the superior affinities of 7b-7e compared to those of
2 and 7a. There are two possible sources of blocker-channel interactions for PEG-QAs:
the PEG backbone and the alkyl substituents of the QAs. Because trimethylammonium
and N-methylpyrrolidium are smaller compared to the other tested QAs, it is likely that
these two groups provide fewer interactions with the hydrophobic wall of the AChR pore
and hence the affinities of 2 and 7a are weaker. Alternatively, the presence of two
independent blockade modes might indicate two types of PEG-QA conformations formed
in the extracellular medium (Figure 3.15). It is likely that each type of the blocker, once
partitioned into the pore, makes different physical contacts with the pore-lining residues.
In this scenario, 7a has a weaker affinity compared to 7b-7e because this compound
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prefers the conformation that leads to faster dissociation. Our data cannot exclude either
explanation.
3.4.4. Effects of the QA Structure on AChR Activation
Like the prototype molecules (PEG-TMAs), 7a-7e are capable of inducing AChR
openings, but their potencies are different. Except for 7d, the agonist potency can be
roughly correlated inversely with the size of the attached QA (Figure 3.3) as judged by
the total open probability (NPo) and mean open time (to). NPo measures the total fraction
of time in which a channel is open. It provides a rough estimate of the overall channel
activity under a given condition. Because simultaneously open channels were rarely seen
in the active patches, the magnitude of NPo is mainly determined by the frequency of
opening (i.e., the number of openings per unit of time) and the duration of the opening
events. Compounds 7c and 7e, with the two largest QAs among the series, are poor
agonists. They induce very low channel activities at 10 p~M (NPo = 10 4-10 -5) due to both
low opening frequencies and brief opening durations (to - 0.2 ms). Two factors might
lead to the low agonist potencies of 7c and 7e. First, steric hindrance by the bulky QAs
may prevent the molecules from binding to the agonist sites. Bakry et al. measured the
inhibition of [3H]ACh binding to Torpedo membranes by symmetric tetraalkylammonium
salts [1] and found that increasing the size of alkyl substitents decreased the QA's affinity
for the agonist sites, suggesting that the agonist sites are less tolerant to bulky
substituents. Second, these molecules may bind to the agonist sites with appreciable
affinities but they may not easily trigger the conformational changes required for channel
gating. Failure to trigger such conformational changes was previously proposed for the
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low potency of partial agonists [28]. Isotope ligand binding assays, such as the
experiments described by Bakry et al., may allow us to further understand the cause of
agonist potency loss for 7c and 7e. It is worth noting that lack of agonist potency may be
a desired feature for an open-channel blocker in some applications. For instance, "non-
depolarizing blockers" of the AChR, i.e., inhibitors that do not induce neuromuscular
activities by themselves, are preferred muscle relaxants in clinical uses [29].
Compound 7d, which is decorated with triethylammonium groups, induces
exceptionally high activity (NPo - 0.01) and long opening durations (to - 0.9 ms) at 10
pM compared to the other PEG-QAs. Tetraethylammonium was previously reported to
stimulate AChR activities [ll], and hence it is not surprising to observe appreciable
AChR activities with 7d. The compound's agonist potency might help explain the
complexity in the closed-time distribution at 20 gLM 7d (with 100 pM ACh) (Figure
3.9E). At a high enough concentration, 7d may be capable of competing with ACh for
the agonist sites and stimulating channel openings. The new arising component in the
closed-time histogram might therefore represent the channel gating component associated
with 7d's binding to the agonist sites.
3.5. Future Perspectives
Combining the results in the present and previous chapters, our work
demonstrates that PEG is a highly versatile scaffold for creating open-channel blockers
that span a broad range of blockade kinetics and affinity. We have defined the basic
functional elements and characterized the mechanism of channel modulation by PEG-
based blockers. However, several questions about the interactions between the AChR
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and PEG-QA conjugates remain to be answered. The proposed experiments and some
possible applications of PEG-QAs are described in this section.
3.5.1. Conclusions from the Current Results
In this thesis work, we explored a new design strategy for open-channel blockers
in which high-resolution structure of the transmembrane lumen is not required. Our
strategy is based on the facts that the transmembrane lumen of an ion channel is mainly
lined with hydrophobic residues and that it has an appreciable capacity for
accommodating organic molecules. The principal concept for this strategy is that a
flexible scaffold, in combination with a pore-directed moiety, is used to allow the blocker
to enter the channel pore. By using a flexible polymeric scaffold, the rate of entering the
pore and the extent of blocker-channel interaction can be quantitatively modulated
according to the physical properties of the polymer backbone.
The proposed strategy has been successfully demonstrated in this thesis work by
using a commonly used polymer, poly(ethylene glycol) (i.e., PEG), as the polymeric
scaffold. By using quaternary ammonium (QA) groups as the pore-directed moieties, the
resulting PEG conjugates are capable of interrupting single-AChR currents at a broad
range of kinetics (k+B: 10-170 M-is-'; kB: 2-35000 s-'), performing open-channel
blockade with various affinities (Kd: 0.1-850 tM). The key conclusions from this thesis
work are summarized as follows:
(1) All of the tested blockers (la-b, 2, 3, 7a-7e) exhibit the characteristic features of an
open-channel blocker: their effects on open-AChR currents are dose- and voltage-
dependent;
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(2) At least one QA group per molecule is required for observable blockade at
micromolar concentrations of PEG-QA. The addition of the second ammonium
group increases the blocker's blocking rate but only marginally affects the unblocking
rate;
(3) The blocking rate constant (k+B) of a bivalent PEG-TMA (TMA =
trimethylammonium) decreases with increasing PEG size: ln(k+B) decreases linearly
with the number of ethylene oxide units (N) in the bivalent PEG-TMA (N = 4-13).
The effect is believed to arise from the entropic cost associated with the partitioning
of a PEG-TMA into the AChR pore;
(4) The unblocking rate constant (k-B) of a bivalent PEG-TMA decreases with increasing
PEG size: ln(k_B) and N loosely follow a linear relationship (N = 4-13). The effect is
believed to arise from the additive non-polar interactions between the ethylene oxide
units and the AChR pore;
(5) Replacing the TMA groups with larger QAs provides higher-affinity blockers. The
effect mainly arises from the decrease in kB. Two modes of blockade have been
found for PEG-QAs (QA : TMA): faster (k-B: 45-85 s-') and slower (k-B: 2-4 s1)
dissociation modes. PEG-QAs with bulkier N-alkyl substituents disfavor the faster
dissociation mode;
(6) The agonist potency of a PEG-QA is greatly affected by the structure of the QA.
Among our tested PEG-QAs, the triethylammonium derivative exhibits the best
agonist potency (NPo - 10-2; to - 0.9 ms at 10 pM), whereas the N-ethylpiperidinium
and N-methyldipropylammonium derivatives are the poorest agonists (NPo - 10-5; to
< 0.2 ms at 10 pM).
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To our knowledge, the work described in this thesis provides the first example of
synthesis and characterization of open-channel blockers derived from poly(ethylene
glycol)s. We have demonstrated that reacting iodide derivatives of PEG with small
tertiary ammines generates a series of open-channel blockers that block the AChR with a
broad range of kinetics and affinities (Tables 2.1 and 3.1; Figure 3.16). Compared to
other open-channel blockers for the AChR (Table 2.2; Figures 3.13 and 3.16), PEG-QAs
have relatively simple structures and great versatilities in functional properties. By
simply changing the backbone length and/or the QA groups, we can prepare PEG-QAs
that block the open AChR with affinities and blocking/unblocking rate constants
comparable to those of other AChR blockers with diverse structures (Figure 3.16 and
Table 2.2). PEG, a commonly used material in biological labs, is therefore a versatile
scaffold in our proposed structure-independent approach for designing open-channel
blockers.
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Figure 3.16. The structures and affinities of the PEG-based blockers characterized in this thesis
work (top). For comparison, several previously reported open-channel blockers for the AChR are
also listed (bottom).
3.5.2. Future Studies on the Modulation of AChR Functions by PEG-QAs
Although our work indicates that PEG-QAs inhibit open-AChR currents via
entering and residing in the transmembrane lumen, our experiments cannot exclude the
possibility that these molecules modulate the AChR in multiple ways. Many of the open-
channel blockers identified so far are believed to bind multiple sites in the AChR, interact
with multiple functional states of the channel, or induce other conformational changes
after blockade [19, 25, 33-35]. To aid the applications of PEG-QAs in the future, it
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would be worthwhile to examine whether our tested PEG-QAs perform AChR inhibition
via mechanisms other than open-channel blockade and whether blockade by PEG-QAs
induces other inhibition pathways (such as blockade-induced channel closure or
desensitization). A more in-depth kinetic analysis, involving a systematic comparison of
the results from MIL analysis/simulation with a variety of possible kinetic models, would
be needed. The best example of this approach is perhaps the mechanistic study of tacrine
inhibition on the AChR [19].
Macroscopic measurements, such as end-plate current decay and ensemble
currents in out-side-out patches, may provide useful information for elucidating the
effects of PEG-QAs on the AChR. For instance, one can study whether PEG-QAs inhibit
AChR opening by incubating the channels with PEG-QAs prior to the addition of ACh
(or other agonists). If the tested blocker binds closed AChRs and prevents them from
opening in response to ACh stimulation, the peak amplitude of the macroscopic current
would be lower than that without the pre-incubation of PEG-QA [12, 32]. It is also of
great value to examine the correlation between the effects observed at the single-channel
and macroscopic levels. As mentioned in Chapter One, fast open-channel blockade leads
to a slower decay in macroscopic currents after stimulation [36], whereas slow open-
channel blockade accelerates the decay [37]. Since our PEG-QAs exhibit open-channel
blockade with various kinetics, we can test whether these molecules cause distinct effects
on macroscopic currents as predicted.
Alternatively, some fundamental questions about the mechanism of action can be
answered by biochemical assays such as isotope ligand binding assays and cross-linking
experiments. For instance, whether PEG-QAs enhance AChR desensitization can be
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examined by comparing the affinity of ACh to the agonist sites in the presence and
absence of PEG-QA. The affinity of ACh can be determined via competition studies
measuring the initial rate of [125 ]C-BTX binding [39]. Compounds that enhance AChR
desensitization have been previously reported to enhance the affinity of CCh or ACh to
the agonist sites [27, 38]. The affinities of PEG-QAs to the agonist sites can also be
determined by measuring the competitive binding between [3H]ACh and PEG-QA [1,
39]. A direct identification of the binding site for PEG-QAs might be possible, provided
that the AChR can be labeled by a photo-affinity reagent derived from PEG-QA. A valid
cross-linking reagent should also block the AChR in a manner similar to that of its parent
PEG-QA.
3.5.3. Possible Applications of PEG-QAs
Due to the lack of a high-resolution structure for the transmembrane lumen, the
rational design of open-channel blockers for the AChR remains challenging. The work
presented in this thesis shows that PEG serves as a useful scaffold for pore-directed
blockers of the muscle-type AChR and that detailed structure of the pore environment is
not needed for blocker design. Because most channels contain a transmembrane pore
surrounded by non-polar residues, perhaps the same strategy can also be used to prepare
open-channel blockers for other channels. For instance, the PEG-QAs studied in this
work may also be potent open-channel blockers for other cation-permeable channels such
as neuronal AChRs, glutamate receptors, and potassium channels. Several blockers of
the muscle-type AChR have also been reported to inhibit neuronal AChRs, indicating that
PEG-QAs are likely to target neuronal AChRs and function in a similar manner [16, 17,
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40-44]. Dicationic compounds were reported to block open glutamate receptors and
acetylcholine receptors [5, 45-47], suggesting that bivalent PEG-QAs are also likely to
target the pore of glutamate receptors. N-alkyl-substituted 1,4-diazabicyclo[2.2.2]octane
(DABCO) salts were found to block two voltage-gated potassium channels (Kv 2.1 and
Kv 3.4) when extracellularly applied, and the potency of the blocker increased with the
length of the alkyl substituent [48]. PEG-QAs are therefore likely to block some types of
potassium channels by interacting with the outer pore of the channels.
In the long-term, PEG-QAs might be suitable for studying the modulation of
synaptic transmission in perfusible experimental preparations such as brain slices, which
retain high degrees of neuronal connectivity and are commonly used in the study of
physiological phenomena (e.g., synaptic plasticity). PEG-QAs are also potentially
versatile building blocks for pore-directed probes. We have shown that only one QA is
needed for observing blockade, and therefore one end of the PEG can be left for
conjugating to an affinity group, a fluorophore, or other useful moieties. It remains to be
tested whether the attachment of other moieties affects a PEG-QA's blockade behavior.
However, if the blockade behavior is not significantly altered, such probes would be
useful for proteomic or cell-biological studies of ion channels. We envision that PEG-
based blockers could be highly useful in a variety of applications in the emerging field of
chemical neurobiology.
- 150 -
References
1. Bakry, N. M., Eldefrawi, A. T., Eldefrawi, M. E., and Riker, W. F., Jr. (1982)
Interactions of quaternary ammonium drugs with acetylcholinesterase and
acetylcholine receptor of Torpedo electric organ. Mol. Pharmacol. 22, 63-71.
2. Neher, E., and Steinbach, J. H. (1978) Local anesthetics transiently block currents
through single acetylcholine receptor channels. J. Physiol. 277, 153-176.
3. Pagain, O. R., Sivaprakasam, K., and Oswald, R. E. Molecular properties of local
anesthetics as predictors of affinity for nicotinic acetylcholine receptors. (2007) J.
Neurosci. Res. 85, 2943-2949.
4. Nojima, H., Kimura, I., Muroi, M., Kimura, M. (1993) Different modes of blockade
byp-phenylene-polymethylene bis-ammonium compounds of the nicotinic
acetylcholine receptor channel in skeletal muscle cells of mice. J. Pharm.
Pharmacol. 45, 309-314.
5. Antonov, S. M., Johnson, J. W., Lukomskaya, N. Y., Potapyeva, N. N., Gmiro, V.
E., and Magazanik, L. G. (1995) Novel adamantane derivatives act as blockers of
open ligand-gated channels and as anticonvulsants. Mol. Pharmacol. 47, 558-567.
6. Pascual, J. M., and Karlin, A. (1998) Delimiting the binding site for quaternary
ammonium lidocaine derivatives in the acetylcholine receptor channel. J. Gen.
Physiol. 112, 611-621.
7. Carter, A. A., and Oswald, R. E. (1993) Channel blocking properties of a series of
nicotinic cholinergic agonists. Biophys. J. 65, 840-851.
8. Sine, S. M., and Steinbach, J. H. (1984) Agonists block currents through
acetylcholine receptor channels. Biophys. J. 46, 277-284.
9. Marshall, C. G., Ogden, D. C., and Colquhoun, D. (1990) The actions of
suxamethonium (succinyldicholine) as an agonist and channel blocker at the
nicotinic receptor of frog muscle. J. Physiol. 428, 155-174.
10. Marshall, C. G., Ogden, D., and Colquhoun, D. (1991) Activation of ion channels in
the frog endplate by several analogs of acetylcholine. J. Physiol. 433, 73-93.
11. Akk, G., and Steinbach, J. H. (2003) Activation and block of mouse muscle-type
nicotinic receptors by tetraethylammonium. J. Physiol. 551, 155-168.
- 151 -
12. Bufler, J., Wilhelm, R, Parnas, H., Franke, Ch., and Dudel, J. (1996) Open channel
and competitive block of the embryonic form of the nicotinic receptor of mouse
myotubes by (+)-tubocurarine. J. Physiol. 495, 83-95.
13. Colquhoun, D., Dreyer, F., and Sheridan, R. E. (1979) The actions of tubocurarine
at the frog neuromuscular junction. J. Physiol. 293, 247-284.
14. Sieb, J. P., Milone, M., and Engel, A. G. (1996) Effects of the quinoline derivatives
quinine, quinidine, and chloroquine on neuromuscular transmission. Brain Res. 712,
179-189.
15. Kimura, M., Kimura, I., Muroi, M., Tanaka, K., Nojima, H., Uwano, T., Koizumi,
T. (1994) The structure-activity relationship between phenylene-polymethylene bis-
ammonium derivatives and their neuromuscular blocking action on mouse phrenic
nerve-diaphram muscle. Biol. Pharm. Bull. 17, 1224-1231.
16. Kertser, S., Bobryshev, A., Voitenko, S., Gmiro, V., and Skok, V. (1998)
Dimensions of neuronal nicotinic acetylcholine receptor channel as estimated from
the analysis of the channel-blocking effects. J. Membrane Biol. 163, 111-118.
17. Gmiro, V. E., Brovtsyna, N. B., Serdyuk, S. E., and Lukomskaya, N. Y. (2002) Ion
channel topology of the neuronal nicotinic acetylcholine receptor:
pharmacochemical approaches. Russian J. Bioorg. Chem. 28, 116-127.
18. Rayes, D., Rosa, M. J., Spitzmaul, G., Bouzat, C. (2001) The anthelmintic pyrantel
acts as a low efficacious agonist and an open-channel blocker of mammalian
acetylcholine receptors. Neuropharmacology 41, 238-245.
19. Prince, R. J., Pennington, R. A., and Sine, S. M. (2002) Mechanism of tacrine block
at adult human muscle nicotinic acetylcholine receptors. J. Gen. Physiol. 120,
369-393.
20. Akk, G., and Auerbach, A. (1999) Activation of muscle nicotinic acetylcholine
receptor channels by nicotinic and muscarinic agonists. Br. J. Pharmacol. 128,
1467-1476.
21. de Wolf, I., and van Driessche, W. (1986) Voltage-dependent Ba 2+ block of K
channels in apical membrane of frog skin. Am. J. Physiol. 251, C696-C706.
- 152 -
22. Bouzat, C., and Barrantes, F. J. (1996) Modulation of muscle nicotinic acetylcholine
receptors by the glucocorticoid hydrocortisone: possible allosteric mechanism of
channel blockade. J. Biol. Chem. 271, 25835-25841.
23. Nurowska, E., and Ruzzier, F. (2002) Modulation of acetylcholine receptor channel
kinetics by hydrocortisone. Biochim. Biophys. Acta 1564, 14-20.
24. Arias, H. R. (1998) Binding sites for exogenous and endogenous noncompetitive
inhibitors of the nicotinic acetylcholine receptor. Biochim. Biophys. Acta 1376,
173-220.
25. Arias, H. R., Bhumireddy, P., and Bouzat, C. (2006) Molecular mechanisms and
binding site locations for noncompetitive antagonists of nicotinic acetylcholine
receptors. Int. J. Biochem. Cell Biol. 38, 1254-1276.
26. Auerbach, A., and Akk, G. (1998) Desensitization of mouse nicotinic acetylcholine
receptor channels: a two-gate mechanism. J. Gen. Physiol. 112, 181-197.
27. Gumilar, F., Arias, H. R., Spitzmaul, G., and Bouzat, C. (2003) Molecular
mechanisms of inhibition of nicotinic acetylcholine receptors by tricyclic
antidepressants. Neuropharmacology 45, 964-976.
28. Lape, R., Colquhoun, D., and Sivilotti, L. G. (2008) On the nature of partial
agonism in the nicotinic receptor superfamily. Nature 454, 722-728.
29. Bowman, W. C. (2006) Neuromuscular block. Br. J. Pharmacol. 147, S277-S286.
30. Alkondon, M., and Albuquerque, E. X. (1989) The nonoxime bispyridinium
compound SAD-128 alters the kinetic properties of the nicotinic acetylcholine
receptor ion channel: a possible mechanism for antidotal effects. J. Pharmacol. Exp.
Ther. 250, 842-852.
31. Amador, M., and Dani, J. A. (1991) MK-801 inhibition of nicotinic acetylcholine
receptor channels. Synapse 7, 207-215.
32. Scheller, M., Bufler, J., Hertle, I., Schneck, H. J., Franke, C., and Kochs, E. (1996)
Ketamine blocks currents through mammalian nicotinic acetylcholine receptor
channels by interaction with both the open and the closed state. Anesth. Analg. 83,
830-836.
- 153 -
33. Aguayo, L. G., Witkop, B., and Albuquerque, E. X. (1986) Voltage- and time-
dependent effects of phencyclidines on the endplate current arise from open and
closed channel blockade. Proc. Natl. Acad. Sci. U.S.A. 83, 3523-3527.
34. Dilger, J. P., Brett, R. S., and Lesko, L.A. (1992) Effects of isoflurane on
acetylcholine receptor channels. 1. Single-channel currents. Mol. Pharmacol. 41,
127-133.
35. Papke, R. L., and Oswald, R. E. (1989) Mechanisms of noncompetitive inhibition of
acetylcholine-induced single-channel currents. J. Gen. Physiol. 93, 785-811.
36. Beam, K. G. (1976) A voltage-clamp study of effect of two lidocaine derivatives on
time course of endplate currents. J. Physiol. 258, 279-300.
37. Huettner, J. E., and Beam, B. P. (1988) Block of N-methyl-D-aspartate-activated
current by the anticonvulsant MK-801: selective binding to open channels. Proc.
Natl. Acad. Sci. U.S.A. 85, 41307-41311.
38. Carp, J. S., Aronstam, R. S., Witkop, B., and Albuquerque, E. X. (1983)
Electrophysiological and biochemical studies on enhancement of desensitization by
phenothiazine neuroleptics. Proc. Natl. Acad. Sci. U.S.A. 80, 310-314.
39. Pedersen, S. E., Lurtz, M. M., Papineni, R. V. L. (1999) Ligand binding methods for
analysis of ion channel structure and function. Methods Enzymol. 294, 117-135.
40. Gurney, A. M., and Rang, H. P. (1984) The channel-blocking action of methonium
compounds on rat submandibular ganglion cells. Br. J. Pharmacol. 82, 623-642.
41. Buisson, B., and Bertrand, D. (1998) Open-channel blockers at the human a4P2
neuronal nicotinic acetylcholine receptor. Mol. Pharmacol. 53, 555-563.
42. Charnet, P., Labarca, C., Cohen, B. N., Davidson, N., Lester, H. A., and Pilar, G.
(1992) Pharmacological and kinetic properties of a4P2 neuronal nicotinic
acetylcholine receptors expressed in Xenopus oocytes. J. Physiol. 450, 375-394.
43. Papke, R. L., Horenstein, B. A., and Placzek, A. N. (2001) Inhibition of wild-type
and mutant neuronal nicotinic acetylcholine receptors by local anesthetics. Mol.
Pharmacol. 60, 1365-1374.
44. Papke, R. L., Buhr, J. D., Francis, M. M., Choi, K., Thinschmidt, J. S., and
Horenstein, N. A. (2005) The effects of subunit composition on the inhibition of
- 154 -
nicotinic receptors by the amphipathic blocker 2,2,6,6-tetramethylpiperidin-4-yl
heptanoate. Mol. Pharmacol. 67, 1977-1990.
45. Magazanik, L.G., Buldakova, S. L., Samoilova, M. V., Gmiro, V. E., Mellor I. R.,
Usherwood, P. N. R. (1997) Block of open channels of recombinant AMPA
receptors and native AMPA/kainate receptors by adamantane derivatives. J.
Physiol. 505, 655-663.
46. Antonov, S. M., Gmiro, V. E., and Johnson, J. W. (1998) Binding sites for permeant
ions in the channel of NMDA receptors and their effects on channel block. Nat.
Neurosci. 1, 451-461.
47. Bolshakov, K. V., Kim, K. H., Potapjeva, N. N., Gmiro, V. E., Tikhonov, D. B.,
Usherwood, P. N. R., Mellor, I. R., Magazanik, L. G. (2005) Design of antagonists
for NMDA and AMPA receptors. Neuropharmacology 49, 144-155.
48. Gordon, E., Cohen, J. -L., Engel, R., Abbott, G. W. (2006) 1,4-
Diazabicyclo[2.2.2]octane derivatives: a novel class of voltage-gated potassium
channel blockers. Mol. Pharmacol. 69, 718-726.
49. Hille B. (2001) Ion channels of excitable membranes, 3rd ed., Sinauer Associates
Inc., Massachusetts, U.S.A.
50. Maconochie, D. J., and Steinbach, J. H. (1995) Block by acetylcholine of mouse
muscle nicotinic acetylcholine receptors, stably expressed in fibroblasts. J. Gen.
Physiol. 106, 113-147.
51. Movileanu, L., Cheley, S., and Bayley, H. (2003) Partitioning of individual flexible
polymers into a nanoscopic protein pore. Biophys. J. 85, 897-910.
- 155 -
Appendix A
Synthesis of a Photoaffinity Probe and a Biotin-Azide Reagent
for State-Selective Labeling of the Acetylcholine Receptor
The molecules described in this section were synthesized for a project in
collaboration with Mathew Tantama. The synthetic methods and structural
characterizations presented in this section have been published in:
Tantama, M., Lin, W. -C., and Licht, S. (2008) An activity-based protein profiling probe
for the nicotinic acetylcholine receptor. J. Am. Chem. Soc. 130, 15766-15767.
A. Overview
Activity-based protein profiling (ABPP) has been successfully applied to many
enzymes but not yet to ion channels [1-3]. A bifunctional photoaffinity probe, named
BPyneTEA (benzophenone-alkyne-triethylammonium; Scheme Al), was synthesized as a
candidate probe for state-selective labeling of the nicotinic acetylcholine receptor
(AChR). There are three functional components in the candidate probe: (1) a quaternary
ammonium group that interacts with the transmembrane electric field and directs the
probe to target the AChR pore; (2) a photoaffinity moiety that covalently labels the AChR;
and (3) an alkyne "handle" that allows installation of a biotin group for the enrichment of
the labeled subunits. The photoaffinity labeling moiety, benzophenone (BP), was
previously reported to preferentially label the closed state (unliganded, non-conducting
channel) over the desensitized state (ligand-bound, non-conducting state) of Torpedo
AChR [4]. The quaternary ammonium moiety, triethylammonium (TEA), not only
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directs the probe to target the transmembrane pore but also improves the probe's
solubility in water (BP is not soluble in water). In order to install a biotin group on the
probe's alkyne handle via a Cu(I)-catalyzed [3+2] cycloaddition reaction (i.e., "click"
chemistry) [5], a biotin reagent containing a terminal azide was synthesized (Scheme A2).
The synthesis of BPyneTEA is summarized in Scheme Al. In brief, BPyneTEA
was prepared by first coupling 4,4'-diaminobenzophenone with 4-pentynoic acid to
install an alkyne handle on the BP moiety. The remaining amino group of the
mono-substituted 4,4'-diaminobenzophenone (BPyne-NH 2) was then reacted with
iodoacetic anhydride to provide the iodide precursor (BPyne-I). Finally, the quaternary
ammonium moiety was installed via an SN2 substitution of BPyne-I by triethylamine.
Biotin-N 3 was prepared by coupling biotin and a commercially available H2N-PEG-N 3
reagent (1-Amino-11 -azido-3,6,9-trioxaundecane, Scheme A2). The
electrophysiological characterization of BPyneTEA and the cell-based photo-crosslining
assay were performed by Mathew Tantama. The results and a discussion about the state
selectivity of the probe have been reported [6]. Detailed synthetic procedures and
spectroscopic assignments for the molecules are described below.
B. Synthetic Methods
General Methods. 1-Amino-11-azido-3,6,9-trioxaundecane was purchased from
Toronto Research Chemicals (North York, ON, Canada). Other chemicals were
purchased from Sigma-Aldrich (Milwaukee, WI) as reagent grade and were used as
supplied. Anhydrous methylene chloride and acetonitrile were packed in Sure/SealTM
bottles and were transferred under nitrogen with a syringe. 'H and '3C NMR spectra
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were recorded on a Varian Mercury 300 spectrometer. Chemical shifts (8) were
calibrated to the residual solvent peak and were expressed in parts per million (ppm).
Coupling constants (J) were reported in Hz. High resolution electrospray mass spectra
were obtained by a Bruker Daltonics APEXIV 4.7 Tesla FT-ICR mass spectrometer.
Analytical thin-layer chromatography (TLC) was performed using silica 60
F254-precoated glass plates (EMD Chemicals Inc., Gibbstown, NJ). Compounds were
visualized by staining with aqueous potassium permanganate. Normal-phase column
chromatography was carried out on Merck® silica gel 60 (70-230 mesh, Aldrich).
Scheme Al. Synthesis of BPyneTEA.
0
H2N 0 NH2
iodoacetic anhydride
CH3CN, 4 h, 60%
25% (v/v) NEt3/acetone
12 h, 93%
OH
DCC, HOBT
DMF, 15 h, 58%
O
0 0
N N
H H
BPyne-I
O
0 0
WO N Nk _1 ByneEH
BPyneTEA
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BPyne-NH 2
Synthesis of BPyne-NH2. To a cooled (0 'C) solution of 4-pentynoic acid (196
mg, 2 mmol), 4,4'-diaminobenzophenone (638 mg, 3 mmol), and 1-hydroxybenzotriazole
(HOBT; 270 mg, 2 mmol) in anhydrous DMF (20 mL) was added
N,N'-dicyclohexylcarbodiimide (DCC; 3 mL of 1.0 M solution in CH 2C12, 3 mmol)
dropwise under an atmosphere of dry N2. The mixture was stirred at 0 'C for 15 min,
and the reaction was allowed to proceed at ambient temperature for 16 h. The reaction
mixture was quenched by cold water (2 mL) at 0 C and then filtered. The filtrate was
concentrated by rotary evaporation and purified by silica gel chromatography (2:1
EtOAc:hexanes) to give BPyne-NH 2 (337 mg, 58%) as a light-yellow solid. TLC (3:1
EtOAc:hexanes) Rf0.40; 'H NMR (acetone-d 6, 300 MHz): 6 9.49 (s, 1H), 7.79 (d, J= 8.7
Hz, 2H), 7.67 (d, J= 8.7 Hz, 2H), 7.61 (d, J= 8.9 Hz, 2H), 6.73 (d, J= 8.9 Hz, 2H), 5.53
(s, 2H), 2.66 (m, 2H), 2.55 (m, 2H), 2.39 (t, J= 2.7 Hz, 1H); 13C NMR (acetone-d 6, 75
MHz): 6 193.7, 170.6, 154.0, 143.0, 134.9, 133.3, 131.3, 126.6, 119.1, 113.8, 83.9, 70.4,
36.6, 14.9; HRMS-ESI (m/z) calcd for C18H17N 20 2 [M + H]+: 293.1285; found:
293.1287.
Synthesis of BPyne-I. BPyne-NH2 (132 mg, 0.45 mmol) and iodoacetic
anhydride (320 mg, 0.9 mmol) were dissolved in anhydrous CH 3CN (10 mL) under an
atmosphere of dry N2. The mixture was stirred at room temperature for 4 h, cooled to 0
'C for 0.5 h, and then filtered. The precipitate was washed with ice-cold CH 3CN (2 x
15 mL) and dried under high vacuum to give BPyne-I (82 mg, 40%) as a white solid.
The combined filtrate was concentrated, washed with MeOH (2 x 5 mL), and dried under
high vacuum to provide more BPyne-I (41 mg, 20%). 'H NMR (DMF-d 7, 300 MHz): 6
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10.83 (s, 1H), 10.47 (s, 1H), 7.91-7.79 (m, 8H), 4.02 (s, 2H), 2.81 (t, J= 2.7 Hz, 1H),
2.70 (m, 2H), 2.58 (m, 2H); 13C NMR (DMF-d7, 75 MHz): 8 194.6, 171.3, 168.5, 144.5,
144.2, 133.9, 133.3, 132.2, 132.1, 119.5, 119.4, 84.4, 71.6, 36.8, 15.1, 1.3; HRMS-ESI
(m/z) calcd for C20H18IN20 3 [M + H]+: 461.0357; found: 461.0369.
Synthesis of BPyneTEA. BPyne-I (60 mg, 0.13 mmol) was dissolved in acetone
(15 mL) and triethylamine (5 mL) was added to reach a final concentration of 25% (v/v).
The reaction was allowed to proceed at room temperature for 12 h, and white precipitate
formed slowly over the course of reaction. The supernatant was removed, and the
precipitate was washed by diethyl ether (3 x 10 mL) and dried by a steady flow of dry N2.
The solid was further dried under high vacuum to give BPyneTEA (55 mg, 75%) as a
white powder. The supernatant and ether washes were combined and another 10 mL of
diethyl ether was added, allowing the precipitation of BPyneTEA from the combined
solution. The precipitate was collected, washed by diethyl ether (3 x 5 mL), and dried
to provide additional BPyneTEA (13 mg, 18%). 1H NMR (CD 30D, 300 MHz): 6
7.79-7.77 (m, 8H), 4.22 (s, 2H), 3.70 (q, J = 7.2 Hz, 6H), 2.65 (m, 2H), 2.56 (m, 2H),
2.31 (t, J = 2.4 Hz, 1H), 1.40 (t, J = 7.2 Hz, 9H); 13C NMR (DMF-d 7, 75 MHz): 6 194.6,
171.3, 164.7, 144.3, 133.7, 132.0 (2 peaks), 121.6, 119.3, 84.4, 71.6, 59.4, 55.0, 36.8,
15.1, 8.4; HRMS-ESI (m/z) calcd for C26H32N30 3 [M - I]+: 434.2438; found: 434.2457.
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Scheme A2. Synthesis of Biotin-N 3.
0
HN NH
S OH EDC,HOBT HN kNH
+ DMF, 15 h, 91% H
H2 N ~OOO N3  O
Biotin-N 3
Synthesis of Biotin-N3. To a cooled (0 °C) mixture of biotin (122 mg, 0.5 mmol),
N-ethyl-N'-(3-dimethylaminopropyl)carbodiimide hydrochloride (EDC, 144 mg, 0.75
mmol), and HOBT (101 mg, 0.75 mmol) in anhydrous DMF (5 mL) was added
1-amino- 11-azido-3,6,9-trioxaundecane (55 mg, 0.25 mmol, diluted in 1 mL of anhydrous
DMF) dropwise. The reaction mixture was stirred at 0 C for 0.5 h and was then
allowed to warm to ambient temperature. The mixture was stirred at room temperature
for 24 h, concentrated by rotary evaporation, and then diluted with MeOH/CHCl 3 (5:95,
15 mL). The organic phase was washed with 1 N HCI (aq) (5 x 10 mL), neutralized with
saturated NaHCO 3 (aq) (3 x 10 mL), and re-extracted with CHC13 (5 x 10 mL). The
combined organic phase was washed with brine (5 x 10 mL), dried over anhydrous
Na2SO4, concentrated by rotary evaporation, and purified by silica gel chromatography
(CHC13 -- 17:83 MeOH:CHC13) to give biotin-N3 (101 mg, 91%) as a white solid. TLC
(1:5 MeOH:CHC13) R 0.40; 'H NMR (CD 30D, 300 MHz): 6 4.50 (m, 1H), 4.31 (dd, J=
8.0, 4.4 Hz, 1H), 3.72-3.58 (m, 10H), 3.54 (t, J= 5.4 Hz, 2H), 3.46-3.32 (m, 4H), 3.21
(m, 1H), 2.93 (dd, J= 12.6, 5.0 Hz, 1H), 2.71 (d, J= 12.6 Hz, 1H), 2.22 (t, J= 7.4 Hz,
2H), 1.80-1.54 (m, 4H), 1.52-1.48 (m, 2H); '3C NMR (CD 30D, 75 MHz): 6 176.2,
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166.2, 71.8 (2 peaks), 71.7, 71.4, 71.3, 70.7, 63.5, 61.8, 57.2, 51.9, 41.2, 40.5, 36.9, 29.9,
29.6, 27.0; HRMS-ESI (m/z) calcd for C18H32N6NaO5S [M + Na]+: 467.2047; found:
467.2045.
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